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ABSTRACT 
 
Over the past decades progress in the field of molecular genetics has had an immense 
contribution to the better understanding of hereditary diseases. Hereditary retinal dis-
orders are a group of diseases that affect the normal function of retina leading to 
partial or complete loss of eye sight. Depending upon the type and severity of the 
disease, loss of vision may occur suddenly or gradually. Despite the age of onset and 
symptoms, eye diseases generally affect the overall quality of life in the affected 
individuals of all races, cultures and ethnicities and thus remained an active area of 
research in the past and will be explored in the future as well. 
 
The current study focused on the genetic analysis of eight consanguineous Pakistani 
families (A-H) with multiple members suffering from autosomal recessive RP or retinal 
dystrophies. These families were enrolled from different rural villages of Pakistan 
including Punjab, Khyber PakhtunKhwa and Sindh provinces. Clinical data of the 
affected members of the families were obtained and diagnosis of RP was made after 
ophthalmic assessment by local ophthalmologist. Physical evaluations ruled out presence 
of extraocular phenotypes. Blood samples were collected from available members of 
families and genomic DNA was isolated for use in genetic analysis. Initially all collected 
families were tested by STS based homozygosity mapping which result in the mapping of 
family B to chromosome 16. Remaining seven families were subjected to SNP based 
genome scan which revealed their mapping to different genomic regions. Further follow 
up of these seven families led to the identification of three novel muta-tions; (c.244-
2A>C) in C8ORF37 (Family C), (c.786delT) FAM161A (Family D) and 
(g.[152634_42094] delins A) LCA5 (Family F) genes. However mutation analysis of 
 
ZNF513, C2ORF71, FAM161A, VSNL1 genes in family A and CLN3 gene in family B did 
not identify any pathogenic variation. Two families (Family E and H) with multiple 
homozygous regions and a third family (i.e family A) underwent RD panel based next 
generation sequencing which only resulted in the identification of a known c.1600G>A in 
family E in TRPM1 gene. Although we identified two heterozygous variants (c.5653 A>G 
and c.14662 A>T) in USH2A gene in family A by RD panel sequencing but these variants 
did not segregate with the disease phenotype in this family. 
 
The splice site mutation (c.244 -2A>C) identified in family C was further analyzed with a 
minigene assay which confirmed the loss of splice acceptor site and the activation of 
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cryptic splice site in exon 3. Sanger sequencing of the cDNA also confirmed the acti-
vation of the cryptic splice site within exon 3 which result in the deletion of 22 
nucleotides from the RNA. This 22 nucleotide deletion probably results in the 
frameshift and premature truncation of the protein. 
 
DNA walking was used to identify the large LCA5 deletion in family F. Sanger 
seuencing of PCR products obtained with DNA walking kit revealed a large homozy-
gous deletion of 110540 bps (g.[152634_42094] delins A) in the LCA5 gene. This de-
letion is predicted to affect the binding site for the basal transcriptional apparatus 
therefore disrupts the transcriptional regulation and normal gene activation. 
 
Family G showed a recurrent mutation c.25G>A in the NMNAT1 gene. While RD 
panel NGS identified a recurrent missense mutation c.1208G>A, (p.Arg403Gln) in 
exon 11 of the CNGB3 in family H which did not segregate with the disease 
phenotype in the family. As this family has been clinically diagnosed with retinitis 
pigmentosa the CNGB3 variant does not segregate with the disease phenotype 
therefore negates the disease causative nature of the variant in this family. 
 
 
Families that did not link to any of the known genes/loci by conventional sequencing 
techniques may have the potential to link to novel genes involved in the pathogenesis 
of retinal dystrophies. Whole exome sequencing or whole genome sequencing may be 
implemented to determine the underlying genetic factors for families A, B and H. 
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This study resulted in one publication, 
 
 Ravesh and El Asrag et al., 2015. Novel C8orf37 mutations cause retinitis pig-
mentosa in consanguineous families of Pakistani origin 
 
Two manuscripts submitted and currently under review 
 
 Ansar and Ravesh et al., 2015. Detection of Novel Mutations Causing Autoso-
mal Recessive Retinitis Pigmentosa in Pakistan 

 Ravesh et al., 2015. DNA walking reveals a large deletion of LCA5 in a 
consanguineous family from Pakistan 
 
Abstracts Presented in International Conferences 
 
 Ravesh Z, Weisschu N, Wissinger B, Ansar M. (2015): Molecular genetic 
analysis of Hereditary Retinal Dystrophies in Consanguineous Families from 
Pakistan. (Asia ARVO 2015, Feb 16 - 19, Yokohama, Japan).  
 
 Ravesh Z, Weisschu N, Reuter P, Bonin M, Ansar M, Wissinger B. (2015): 
Molecular genetic analysis of Autosomal Recessive Retinitis Pigmentosa & 
Leber congenital amaurosis in Pakistani Population (25th Annual Meeting of 
the German Society of Human genetics, ESSEN 2014).  
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Chapter 1 Introduction 
 
 
INTRODUCTION 
 
1.1 The Human Eye 
 
The human eye is a sensitive organ that confers vision and color discrimination, and 
these functions are mainly performed by different types of photoreceptor cells. The 
human eye is capable of distinguishing nearly 10 million colors (Judd et al., 1975). 
The eye consists of three different layers i.e outer, secondary and interior and it’s the 
later that contains photoreceptor cells. The outer layer is composed of sclera and 
cornea and is known to contain fibrous tissues that support the eyeball wall (Atchison 
and Smith, 2000). The secondary layer is divided into iris (pigmented and control 
light exposure), ciliary body (produce crystalline fluid) and choroid (transport oxygen 
and nutrients to retina). Additionally eye also contains three fluid chambers i.e frontal 
cavity, the rear cavity and the vitreous chamber. 
 
1.2 The Retina 
 
Retina is a special lining of the interior surface of eye, and is capable of transforming 
light signals into electrical signals which are transmitted to the visual centers of brain 
via the optic nerve. The vertebrate retina has a complex multilayered structure and is 
mainly composed of layers of nerve fiber, ganglion cell, inner and outer plexiform, 
inner and outer nuclear and photoreceptor cells. The inner nuclear layer and inner and 
outer plexiform layers are tightly packed cell layers of neuronal synapses that transmit 
information (Ayoub and Matthews., 1992 and Kolb et al., 1994) while the outer 
nuclear layer and outer limiting membrane are filled with rods and cones therefore 
known as light-detecting section of the eye (Omri et al., 2010). 
 
1.2.1 Photoreceptors 
 
Photoreceptors are specific neurons capable of phototransduction. This process 
transforms light into nerve signals that can be communicated to the brain via optic 
nerve. This process begins when a photon hits a photoreceptor, and change its 
membrane potential resulting in the activation of signal transduction pathway. Initially 
vertebrate retina was thought to be composed of two types of photoreceptor cells i.e 
rods and cones, however in 1991 Foster et al., implied the presence of a third 
photoreceptor cell type referred as ganglion cells. There are nearly 1.2 million retinal 
ganglion cells that transform visual information from photoreceptors to the brain. 
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There are 120 million rods and 6 million cones located in the outer zone of retina and 
share similar basic structure (Koenekoop, 2009). 1) Synaptic terminal that create a 
synapse with other neurons. 2) An inner segment with nucleus and other 
mitochondria. 3) Outer segment behind the eye and contains light absorbing features 
(Kandel et al., 2000). The outer segment consists of numerous disks where the photo 
pigments exist as transmembrane proteins. They also contain an opsin and the 
chromophore 11-cis-retinal (Reme and Wenzel, 2003) (Figure 1.1). Photoreceptor 
cells continuously generate new outer segments while the mature outer segment is 
released to be engulfed by the retinal pigment epithelium (RPE) (Kevany et al., 2012). 
 
1.2.1.1 Rod Photoreceptors 
 
Rod photoreceptors are mainly concentrated in the outer segments of retina and are 
100 times more sensitive to a single photon (Okawa et al., 2007) as compared to the 
cone cells. As a result these cells can function in dim lights and are responsible for the 
night vision. Rods are long (100-120µm) and slim cells that contain: 1) membranous 
disks filled with visual pigments (Rhodopsin). Rhodopsin is responsible in initiating 
light perception and also enables the observation of shades of gray. 2) An inner 
segment containing mitochondria, ribosomes and membranes where opsin molecules 
are assembled and transferred to the outer segment. 3) A cell body that holds the 
nucleus of rod photoreceptors and 4) A synaptic end where neurotransmission to other 
neurons take place (Luo et al., 2008). 
 
1.2.1.2 Cone Photoreceptors 
 
Cones are designed for color vision and operate under vivid illumination. They are 
capable of perceiving details and rapid changes in images, because they have a faster 
response to stimuli than those of rods and therefore more suitable for detecting 
moving objects (Kawamura et al., 2008). The inner and outer segments are joined by 
the cilium (Kandel et al., 2000). Cones are typically 40–50 µm long, and their 
diameter varies from 0.5 to 4.0 µm being tightly packed in the fovea. Based on their 
response to different light wavelengths, cones are stratified into three types and are 
named as S, M and L cone cells. The first type (S) responds to short-wavelength light 
of 420–440 nm, second type (M) responds to 534–545 nm peaking at green color and 
the last type responds to 564-580 nm (Hunt., 2004). 
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Figure 1.1 Structure of rod and cone photoreceptor. The arrow depicts the light 
 
direction. (http://www.ganfyd.org) 
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1.2.2 Retinal Pigment Epithelium 
 
Retinal pigment epithelium (RPE) is a densely pigmented layer of 4-6 million cells 
attached to the underlying retinal visual cells that is responsible for the nourishment of 
the retinal cells and is believed to act as a barrier of choroidal fluorescence (Strauss., 
2005). The choroid contains melanocytes to reduce the fluorescence from the deeper 
vessels (Boyer et al., 2000). The main functions of RPE include light absorption, 
visual cycle, epithelial transport, phagocytosis, secretion and immune modulation. 
When light is focused on the macula it results in a great amount of photo-oxidative 
energy in the retina (Winkler et al., 1999; Beatty et al., 2000). Photo-oxidation 
damages the outer segment tips of photoreceptor cells leading to a continuous renewal 
process which is also assisted by phagocytosis of destroyed photoreceptor outer 
segments by the RPE. Therefore RPE has to maintain the structural integrity of the 
retina by a protection against free radicals, photo-oxidative exposure and light energy 
(Beatty et al., 2000). 
 
1.3 Phototransduction Cascade 
 
The components of this cascade although functionally similar but are uniquely 
expressed in the photoreceptors (Vadim et al., 2002). Photoreceptors uniformly sense 
the light with their photopigments comprised of a vitamin A-based chromophore and a 
seven-transmembrane-helix apoprotein, opsin. These pigments are G protein-coupled 
receptors (GPCRs) (Yau and Hardie 2009). Phototransduction occurs in the outer 
segment of the photoreceptor cells rich in rhodopsin (RHO) visual pigment. RHO 
triggers the G protein transducin (Gt) to stimulate the cGMP-phosphodiesterase 
(cGMP-PDE) to hydrolyze cGMP to 5'-GMP. Upon induction of light there is a rapid 
decrease in free cGMP therefore closure of cGMP-gated channels hyperpolarize the 
rod cells and reduce the glutamate release. Hydrolysis of GTP to GDP inactivates 
transducin and phosphodiesterase (PDE) (Yau and Hardie., 2009). The enzyme 
responsible for the synthesis of cGMP from GTP is Guanylate cyclase which is 
inactivated on the drop of intracellular Ca2+ (Figure 1.2). Although low levels of light 
leads to the termination of RHO but decline of the light response is effectively 
speeded by multiple negative-feedback mechanisms mediated by Ca2+ (Koutalos and 
Yau, 1996). The Ca2+ feedback plays a critical role in controlling the fluctuations of 
free cGMP which otherwise apart from producing noise can be harmful to the cell by 
opening excessive number of cGMP-gated channels (Yau, 1994; Burns et al., 2002). 
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Figure 1.2 Flow chart of the steps involved in Phototransduction cascade. 
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1.4 Visual Cylce 
 
The visual cycle 'retinoid cycle' is the regeneration of visual pigments. Photon 
absorption triggers the G protein–coupled receptors 'opsins' which are bound to light 
absorbing element (chromophore) derived from 11-cis-retinal (Johnson et al., 2003). 
This process generates the isomerization of 11-cis retinal (11-cis-RAL) to all-trans-
retinaldehyde (all-trans-RAL) leading to structural alterations that initiate visual 
transduction cascade. The released all-trans-RAL is reduced to all-trans-retinol (all-
trans-ROL) by NADPH dependent retinol dehydrogenases (RDHs) RDH10 and 
RDH11 in the outer segment (Jang et al., 2000; Rattner et al., 2000; Kolesnikov et al., 
2007: Travis et al., 2010). The All-trans ROL is then transferred to the RPE cells by 
carrier protein – Interphotoreceptor Retinoid-Binding Protein (IRBP) (Lai et al., 1982) 
where it is esterified to all-trans retinyl ester (all-trans-RE) by lecithin retinol 
acyltransferase (LRAT) (Mondal et al., 2000). The all-trans RE is then transformed to 
11-cis-ROL by RPE65 (Gollapalli et al., 2003; Redmond et al., 2005). While attached 
to another protein called Cellular Retinaldehyde Binding Protein (CRALBP), 11-cis-
ROL is oxidized to 11-cis-RAL and exits the RPE to extracellular interphotoreceptor 
matrix (IPM) where it can conjugate to an opsin to form a new functional visual 
pigment (Saari et al., 2009). 
 
There is a dramatic difference in the rates of dark adaptation of the two photoreceptor 
cells, which implies that visual pigment is regenerated substantially faster in cones 
compared to rods (Golobokova EY and Govardovskii., 2006). Furthermore rods tend 
to saturate in light conditions close to twilight whereas cones remain functional and 
do not saturate even in very bright light (Penn and Hagins., 1972). Mutations in either 
of the proteins or enzymes involved in this mechanism will cause different types of 
retinal degenerations. These will be discussed in detail in the following sections. 
 
1.5 Retinal Degenerations 
 
Retinal degeneration (RD) is one of the major causes of blindness described by 
deterioration of photoreceptor and RPE cells. They are generally classified based on 
the photoreceptor cell which is primarily affected in RPE cells and follow different 
patterns of inheritance i.e autosomal recessive (AR), autosomal dominant (AD), or X-
linked (XL). Because of their similarities, these retinopathies including Retinitis 
Pigmentosa, Leber Congenital Amaurosis, Congenital Stationary Night Blindness, 
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Stargardt's disease, Cone Rod dystrophy, Cone dystrophy (CD) and Achromatopsia, 
show clinical and genetic overlap (den Hollander et al., 2010). 
 
1.5.1 Cone-Rod and Cone Dystrophy 
 
Cone-rod dystrophy (CRD) is an inherited retinal degeneration belonging to the group 
of pigmentary retinopathies characterized by primary loss of cone photoreceptor cells, 
gradually followed by loss of rod photoreceptors. CRDs have two modes of 
inheritance: autosomal dominant and autosomal recessive with a prevalence of 
1/40,000 (Hamel, 2007). In comparison to RP, CRDs are characterized by initial 
involvement of cone photoreceptors followed by rod cells or in some cases by 
simultaneous loss of both photoreceptors (Hamel, 2007). At the end stage however RP 
and CRDs show the same features. 
 
CD is an inherited ocular disorder with loss of cone photoreceptors responsible for 
central vision and color vision. Patients initially show regular cone function but later 
develop severe loss of visual acuity, color vision defects and photophobia by the first 
or second span of life. 
 
1.5.2 Achromatopsia 
 
Achromatopsia (ACHM) is an autosomal recessive cone dystrophy characterized by 
poor vision, light sensitivity, nystagmus, severe color vision deficiency, diminished 
cone ERG responses, and normal rod ERG responses with a prevalence of 1:30,000 
(Sharpe et al., 1999). Nonetheless visual acuity of ACHM patients typically worsens 
to total blindness prior to age of forty (Michaelides et al., 2004). Achromatopsia is 
also known as color blindness due to absence of cone function (Simunovic et al., 
1998). The four CNGA3, CNGB3, GNAT2 and PDE6C genes that code the cone 
phototransduction cascade proteins are related to achromatopsia (Jay Neitz and 
Maureen Neitz., 2011). 
 
1.5.3 Stargardt Disease 
 
Stargardt disease also known as fundus flavimaculatus is a common inherited form of 
juvenile macular dystrophy with progressive vision loss having 1:10,000 prevalence 
worldwide. STGD usually strikes in early childhood (age of 6) or early adolescence 
(age of 12) but may also appear later in life (den Hollander et al. 2010). It is 
characterized by Macular atrophy, accumulation of lipids, proteins, and fluorescent 
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compounds, resulting in continuous retinal/macular changes (Walia et al., 2009). 
STGD is associated with several genes ABCA4, CNGB3, ELOVL4 and PROM1 
(Robert et al., 2010; Battu et al., 2015). 
 
1.5.4 Leber Congenital Amaurosis 
 
Leber congenital amaurosis is a severe heterogeneous retinal disorder with autosomal 
recessive inheritance that primarily affects the retina and is characterized by 
nystagmus, sluggish pupil responses and low or non-detectable electroretinography 
(ERG), causing extreme visual damage or blindness that represents itself before the 
age of one (Corton et al., 2013). The impairment tends to be stable, although it 
gradually worsens over time. LCA is associated with five other problems such as 
increased photophobia, nystagmus, and extreme farsightedness (hyperopia). There is 
lack or improper reaction of pupils to the amount of light entering the eye causing 
them to expand or contract more slowly. Individuals with LCA usually do not achieve 
visual acuity better than 20/400 (Cremers et al., 2002). Additionally the cornea 
becomes extremely thin and cone shaped, a condition called keratoconus. Sunken eye 
appearance is observed in many patients due to poking, pressing, and rubbing of the 
eyes (Fazzi et al., 2003). Leber congenital amaurosis was first defined by Theodor 
Leber in 1869 and 1871 on the basis of clinical findings (Leber 1869, Leber 1871). 
LCA is the most common cause of blindness in children, affecting 2 to 3 per 100,000 
newborns. During conception, the fetus of a sibling with LCA, has a 25% chances of 
being affected, 50% chances of being carrier, and a 25% chance of being normal 
(Weleber et al 2004). Till date 18 genes have been reported in LCA (Table 1.1), 
causing approximately 70% of the cases among which mutations in CEP290 (15%), 
 
GUCY2D (12%) and CRB1 (10%) are most prevalent (den Hollander et al., 2008). 
RPE65 mutations also account for 5%–10% of all cases showing high expression 
levels in the RPE and is responsible for encoding a retinoid isomerase enzyme 
required for production of chromophore that makes the visual pigment of the rod and 
cone photoreceptors in the retina. The genes related to LCA encode proteins with a 
variety of functions such as phototransduction (AIPL1, GUCY2D), photoreceptor 
morphogenesis (CRB1, CRX), guanine synthesis (IMPDH1, CEP290, LCA5, 
RPGRIP1, TULP1), vitamin A cycling (LRAT, RDH12, RPE65), and phagocytosis of 
the photoreceptor outer segment (MERTK) (den Hollander et al., 2008). Although 
LCA patients suffer from a variety of retinal dysfunctions, detection of several ciliary 
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encoding protien genes such as CEPP290, IQCB1, LCA5, SPATA7, RPGRIP1 and 
 
TULP1 associated with LCA suggests the vital role of connecting cilia and ciliary 
transport mechanism of the photoreceptor cells in LCA pathogenesis. So far the exact 
underlying LCA mechanisms are not well understood but based on current data, one 
possible reason could be related to defective transport system across the photoreceptor 
connecting cilium (CC) which is the only channel between IS (containing cells 
metabolic machinery and protein production) and OS (discs containing 
phototransduction proteins) of photoreceptors causing faulty transport of proteins 
crucial for maintenance and function of the cell (José-Alain Sahel). Connecting cilia is 
an exclusive transition zone for the transport of proteins and membrane vesicles, also 
called as intra-flagellar transport (IFT), between the inner segment and outer segment 
of the photoreceptor cells (Boldt et al., 2011). The trafficking of proteins is essential 
for efficient phototransduction (Rosenbaum et al., 1999). Depending on the affected 
gene, age of intervention and severity of the phenotype, LCA can becomes more and 
more challenging. 
 
1.5.4.1 Diagnosis of Leber Congenital Amaurosis 
 
Leber congenital amaurosis (LCA) is a severe retinal dystrophy that usually occurs 
before the age one. Poor vision is accompanied by poor or near-absent pupillary 
response, nystagmus, photophobia, high hyperopia and keratoconus. Eye poking, 
rubbing and pressing is often observed in patients. Fundus has variable appearance 
while the retina may initially appear normal but pigmentary deposits are observed 
later in childhood (Weleber et al., 2004). While there is no standard criteria available, 
certain conspicuous features suggestive: 
 
• Extreme visual impairment during infancy before the age of six months; LCA 
individuals hardly achieve visual acuity above 20/400 (Cremers et al., 2002).  
 
• Severely reduced or absence of scotopic and photopic electroretinogram (ERG) 
responses; Normal ERG results reject the diagnosis of LCA.  
 
• The oculo-digital signs; Poking, rubbing, and/or pressing of the eyes (Fazzi et al.,  
 
2003). These characteristics have been claimed to be virtually pathognomonic for 
LCA, nevertheless they may also appear in other visual impairments. 
 
• Family history of autosomal recessive inheritance. 
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1.5.4.1.1 Retinal Findings 
 
Retinal lesions are not prominent in LCA cases, infants may present a normal 
fundus or mild retinal pigments, retinal vessel thinning and macular atrophy but 
abnormalities will appear in the later years. 
 
1.5.4.1.2 Molecular Genetic Testing 
 
Identification of mutations in genes known to cause LCA. 
 
1.5.4.1.3 Testing Strategies 
 
In order to select the candidate genes a chart is to be prepared for evaluation of 
photophobia, hyperopia, retinal abnormalities, nystagmus and ERG (Hanein et al., 
2004). 
 
 LCA Panel Testing: A panel testing of a wide number of LCA associated 
genes. 

 Carrier Testing: This test is conducted on the relatives of the LCA patient 
who are heterozygotes for this recessive disorder, therefore being carriers of 
these mutations. This test requires previous identification of the disease-
causing mutations. 

 Prenatal diagnosis: Performed in case of risky pregnancies. A prior 
knowledge of the disease causing mutation is necessary. 
 
1.5.5 Congenital Stationary Night Blindness 
 
Congenital stationary night blindness (CSNB) is a group of non-progressive 
heterogeneous retinal disorders present since birth and characterized by reduced dim 
light vision followed by myopia, nystagmus and strabismus (Raghuram et al., 2013) 
that is inherited according to all Mendelian inheritance patterns. Visual acuity often 
ranges from 20/30 to 20/200 often accompanied by myopia ranging from low (-0.25 
diopters [D] to -4.75 D) to high (≥-10.00 D) (Boycott et al., 2008). In all three modes 
of inheritance, initially the night vision is congenitally but non-progressively affected 
while retinal examination remains normal. Many CSNB patients also present 
congenital nystagmus which can create a challenge in the differential diagnostic with 
Leber congenital amaurosis. Generally, patients suffering from X-linked congenital 
stationary night blindness also show moderate-to-high myopia. CSNB is caused by 
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defective signaling pathway from photoreceptor to bipolar cells, leading to low or 
complete lack of b-wave and a normal a-wave in the electroretinogram (ERG). Based 
on the electroretinogram (ERG) responses, CSNB has been classified into two types. 
Type 1 CSNB1 or 'complete' cCSNB1 (MIM 310500) is characterized by defects of 
the ON bipolar cells causing faulty transmission of signals to bipolar cell hence 
leading to a drastically reduced rod b-wave response associated with absence of rod 
function (Audo I et al., 2008; Traboulsi EI et al., 2012). . Type 2 or 'incomplete' 
icCSNB (MIM 300071) is characterized by defects of the photoreceptor terminal 
therefore altering photoreceptor transmissions to both ON and OFF bipolar cells 
leading to impaired rod and cone functions(Aparna Raghuram et al., 2013, Maria M et 
al., 2009). Mutations in the two main genes (NYX) which is a member of the small 
leucine-rich proteoglycan nyctalopin gene that encodes the extracellular protein 
nyctalopin and the GRM6 gene encoding the metabotropic glutamate receptor 
mGluR6 commonly play a significant role in autosomal recessive and X-linked 
complete CSNB. NYX gene was identified in majority (45%) of the X-linked 
recessive complete CSNB cases and is considered as the only possible causative gene 
whereas GRM6 gene has only been reported in few of the autosomal recessive 
families with complete CSNB therefore implying the involvement of other unknown 
genes in autosomal recessive complete CSNB (Pusch et al., 2000, Dryja et al., 2005). 
Mutations in the CACNA1F gene account for 55% of incomplete CSNB (CSNB2A) 
cases. Thus far mutations in 17 genes including NYX, CACNA1F, GRM6, TRPM1, 
GPR179, LRIT3, CABP4, CACNA2D4, SLC24A1, RHO, GNAT1, PDE6B, GRK1, 
SAG, RDH5, RPE65, RLBP1 are known to be associated with different inheritance 
patterns of CSNB, Oguchi disease, and fundus albipunctatus presenting a good 
genotype–phenotype correlation (Malaichamy et al., 2014) (Table1.2). 
 
1.5.5.1 Clinical Diagnosis of CSNB 
 
 
Diagnosis of CSNB relies on the electroretinography (ERG) findings, family history, 
and molecular genetic testing. Accurate clinical diagnosis can be made with the 
following findings: 
 Reduced visual acuity: Vision is reduced in most patients ranging from 20/30 
to 20/200. 
 Defective dark adaptation: In order to assess the changes in the retinal 
response to light, ERG test is performed. Light stimulation leads to the 
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depolarization of ON bipolar cells causing the b-wave formation. This process 
is strictly dependent on the synaptic signals from photoreceptors to ON bipolar 
cells. 
 
 Myopia: Nearsightedness can range from low (-0.25 diopters [D] to -4.75 D) 
to high (≥ -10.00 D). Hyperopia has also been observed in a few patients. 

 Nystagmus & strabismus: A significant percentage of patients have shown 
nystagmus and strabismus. 

 Normal color vision: Individuals with a severe X-linked CSNB may show 
mild color vision deficits. 

 Normal fundus examination: Those with high myopia may show myopic 
degeneration. 


 Genetics Counseling: Genetic counseling can provide individuals with 
information on the nature of inheritance and implication of genetic disorders to 
make informed medical and personal decisions. 
 
1.5.6 Retinitis Pigmentosa 
 
Retinitis Pigmentosa (RP) is a heterogeneous disorder represented by loss of 
photoreceptor cells effecting the retina and leading to partial or complete blindness 
(Kanski., 2007). It is initiated by night blindness and gradually continued by the loss 
of peripheral vision and tunnel vision formation. Although disrupted night vision, 
tunnel vision, bone spicule formation, and photoreceptor degeneration are the 
predominant features of RP, but the clinical appearance and severity depends on the 
inheritance pattern and the nature of mutation in the causative gene. Although exact 
reasons for these variations are not very clear but most probably arise due to the 
interaction among genes and their environment (Chang et al., 2011). 
 
Retinitis Pigmentosa (RP) is a sub group of the pigmentary retinopathies. It is a 
heterogeneous disorder characterized by progressive degeneration of photoreceptor 
cells and RPE eventually affecting the retina and leading to loss of vision (Kanski JJ., 
2007). The name Retinitis pigmentosa was first introduced in 1857 by Dr. Donders 
(Van et al., 2011). RP is known to be the most frequent cause of hereditary blindness 
with a prevalence of about 1 in 4000 and about 1.5 million people suffering 
worldwide (Dryja., 1992). Retinitis pigmentosa is usually initiated by loss of night  
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vision in childhood creating difficulties of navigation in low light. Over time as the 
disease progresses retinal pigment deposits in the mid periphery of the retina that 
gradually lead to loss peripheral vision and formation of tunnel vision. Other features 
include waxy pallor of the optic disc, narrowing of the retinal vessels, loss of 
photoreceptor cells and depigmentation of retinal pigment epithelium. Progression of 
this degenerative disease takes over years or even decades to affect the central vision 
which is necessary for detailed tasks such as reading, driving and face recognition. 
Many people with RP become legally blind in adulthood. Those in the advanced 
stages will show very little or non-detectable electroretinograms (ERGs). 
 
Mutations in over 50 genes are known to cause RP which only account for about 50% 
of the existing diseases (Hartong et al., 2006) (Table 1.2). So far 20 genes related to 
autosomal dominant RP (adRP), 32 genes in autosomal recessive RP (arRP) and 5 for 
X-linked RP (xlRP) have been identified (RetNet, the Retinal Information Network, 
provided by the University of Texas Houston Health Science Center, Houston, TX) 
(Ma et al., 2015). These include genes encoding components of the phototransduction 
cascade, visual cycle, proteins involved in retinoid metabolism, cell–cell interaction 
proteins, photoreceptor structural proteins, transcription factors, intracellular transport 
proteins, and splicing factors (Hims et al., 2003). However, the precise function of 
many RP genes still remains unknown. 
 
Although most RP cases are monogenic but there have also been reports of rare 
digenic forms in which heterozygous mutations in ROM1 in combination with 
heterozygous mutations in RDS cause digenic RP (Kajiwara et al., 1994). There have 
also been reports on RP associated with mitochondrial DNA (mtDNA) (Mansergh et 
al., 1999). 
 
1.5.6.1 Autosomal Dominant RP 
 
Autosomal dominant disorders rely on only one mutated copy of the gene and each 
affected individual usually has one affected parent (Griffiths et al., 2012). 20-40% of 
all RP cases are autosomal dominant (Lori et al., 2006). Mutations in 22 genes are 
known to cause adRP (Ma et al., 2015). 
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1.5.6.2 X-Linked RP 
 
The genes associated with X-linked retinitis pigmentosa are located on the X 
chromosome. In males one altered copy of the gene is enough to cause the disease 
whereas in females both genes of the x chromosome must be mutated. X-Linked 
retinitis pigmentosa which accounts for 10% to 15% of the cases is the most severe 
type of RP with the earliest possible onset and rapid deterioration. Till date mutations 
in five genes have been mapped for x-linked RP (Ma et al., 2015). 
 
1.5.6.3 Autosomal Recessive RP 
 
Autosomal recessive disorders depend on mutation of both copies of the gene. 
Affected individuals usually have unaffected parents who each carry a single copy of 
the mutated gene (carriers), hence there are 25% chances of two carrier parents having 
an affected child. The arRP is reported to be much more severe and has an earlier 
onset in comparison to adRP. Mutations in 32 genes are identified to be associated 
with arRP most of which are responsible for only 1-5% of the cases (Ma et al., 2015). 
Autosomal recessive RP is the most common form of retinitis pigmentosa worldwide 
and accounts for 20% to 25% of the total cases. Mutations in certain genes including 
(RPE65, PDE6A, PDE6B and RP25) have higher percentages of all arRP cases 
(Ferrari et al., 2011). Retinal pigment epithelium 65 (RPE65) is expressed in the 
epithelium and is vital for regeneration of the visual pigment. PDE6 is an essential 
component of phototransduction cascade by regulating the levels of cGMP upon light 
activation of the G protein coupled receptor (Tsang et al., 1998). Mutations in other 
genes such as RP25 account for rare arRP cases (Barragan et al., 2008). 
 
1.5.6.4: Syndromic RP 
 
RP is mainly confined to the eye (non syndromic RP) but there are significant 
numbers of individuals suffering from retinitis pigmentosa associated with other 
syndromes in the body. 
 
Frequent Syndromes 
 
The most frequent syndromic type of RP is Usher syndrome which is associated with 
congenital neurosensory deafness. Usher syndrome is both clinically and genetically 
heterogeneous. There are three types of Usher syndrome based on vestibular 
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dysfunction and the degree of hearing loss. In type I (USH1) the hearing loss is 
profound accompanied with vestibular dysfunction from birth, Type II (USH2) is the 
most frequent with moderate hearing conditions and normal vestibular responses and 
Type III (USH3) is characterized by a progressive loss of hearing in the first decade 
(Roux., 2005). So far mutations in 12 loci are known to cause Usher syndrome 
(Hilgert et al., 2009). 
 
Bardet Biedl syndrome (BBS) is a ciliopathic disorder which affects individuals in the 
early childhood. It is less frequent compared to Usher syndrome with a prevalence of 
1/150,000 (Beales et al., 2009). BBS produces many effects such as retinitis 
pigmentosa, renal failure, obesity, hypogonadism and in some cases also mental 
retardation (Beales et al., 2009). Currently 15 BBS genes are identified to cause this 
heterogeneous syndrome (Harville et al., 2010). Mutations in BBS genes are linked to 
ciliary, basal body or centrosomal dysfunction and some are associated with intra-
flagellar transport (IFT) (Blacque et al., 2004). Nevertheless, the exact mechanism 
involved in these actions still remains elusive. 
 
Refsum disease is also known as heredopathia atactica polyneuritiform is a genetically 
rare and heterogeneous autosomal recessive disorder designated by accumulation of 
phytanic acid in due to phytanoyl-CoA hydroxylase (PHYH) deficiency (Sacha 
Ferdinandusse et al., 2008). It is characterized by early onset retinitis pigmentosa, 
polyneuropathy and cerebellar ataxia. Genetic defects in PHYH and PEX7 and disrupt 
the breakdown of phytanic acid resulting in the build-up of phytanic acid which is 
toxic to cells (Jansen et al., 2004). Neuropathy, ataxia, and retinitis pigmentosa 
(NARP) is a clinically heterogeneous mitochondrial disorder mainly affecting the 
nervous system showing typical RP manifestations (Chowers et al., 1999). 
 
1.5.6.5 Prevalence   of   Syndromic   &   non-Syndromic   Retinal 
 
Dystrophies in Pakistan 
 
Based on a comparative study on the genetic causes of RD in Pakistan (Muhammad et 
al., 2014) the most commonly occurring form of RD is autosomal recessive RP. Till 
date fifty six reports on the genomic basis of non-syndromic RD in Pakistani 
population have revealed a high genetic prevalance of arRP (59%), arLCA (19%), 
arCRD (10%), and arCSNB (9%). With respect to the 132 genes currently identified 
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in non-syndromic RD, mutations in 36 various genes are the common cause of RDs 
among Pakistani patients. The most frequent reported genes involve AIPL1 (MIM# 
604392), CRB1 (MIM# 604210), TULP1 (MIM# 602280), RPGRIP1 (MIM# 
605446), RP1 (MIM# 180100), SEMA4A, LCA5 (MIM# 611408), and PDE6A (MIM# 
180071). 
 
Furthermore records of 52 syndromic RD families revealed the occurrence of Usher 
syndrome (36%), BBS (33%), MKS (13%), JBTS (10%), and SLSN (8%), in 
Pakistan. The most prevalent genes include cadherin 23 (CDH23; MIM# 605516), 
followed by TMEM67 (MIM# 609884). 
 
1.5.6.6 CLINICAL MANIFESTATIONS 
 
Fundoscopy reveals arteriolar narrowing, pigment deposition, and absence of RPE. 
During disease progression, vascular narrowing and waxy pallor of the optic disk will 
be enhanced. Fine colorless particles composed of granules of free melanin pigment, 
pigment epithelium; uveal melanocytes and macrophage-like cells may appear (Pagon 
et al., 2005). Later stages of RP include cataract, inflammation of Müller cells and 
disruption of the blood-retinal barrier leading to macular edema therefore affecting the 
central visual acuity. As a consequence of progressed stages of RP, individuals may 
experience retinal detachment and lipid accumulation, a condition known as pseudo-
Coats’ disease. 
 
1.5.6.6.1 Visual Field 
 
A major symptom of most retinal dystrophies is continuous impairment of peripheral 
vision. Visual field testing is the examination of central and peripheral vision. This 
can be done by Goldmann visual field testing that involves a mobile target against a 
bright background and tests out to 90o temporally. Patients in the primary stages show 
a patchy mid-peripheral field loss 20-25o from fixation (Pagon et al., 2005). 
 
1.5.6.6.2 Visual Acuity 
 
The visual acuity test is a routine and general yet very important eye examination to 
detect the changes or problems with proper vision. This is a standard test performed 
by doctors all over the world. For this purpose a distance of 20 feet has to be 
maintained between the patient and the Snellen chart which is a standard chart used to 
measure visual acuity. Each line of the chart is expressed as a fraction that represents 
the patient’s visual acuity. It is calculated as: 
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Visual acuity = Distance at which the patient stands from the chart (20 feet) / Distance 
at which a normal eye can read the smallest symbol. 
 
1.5.6.6.3 Slit-lamp Examination 
 
Slit-lamp is a microscope with a high-intensity light source used to observe the 
anatomy of the frontal and posterior portions including the eyelid, sclera, conjunctiva, 
iris, lens and cornea. The slit-lamp consists of a motin light source and a binocular 
microscope by which the eye structures is examined in detail, enabling a possible 
diagnoses for various eye conditions such as Cataract, Retinal detachment, Corneal 
injury, Retinitis pigmentosa and etc. The test involves adding drops in the eye to dilate 
the pupils to examine the back of the eye. 
 
1.5.6.6.4 Dark Adaptation 
 
Nyctalopia is one of the earliest symptoms of RP. The dark adaptation test is 
conducted for evaluation of night blindness. Rods cells are typically more sensitive to 
light and take around 30-60 minutes to fully adapt to light. Changes in rods and cones 
sensitivity are major contributors to dark adaptation. Above a certain illumination 
level the cones become responsive and below this level the rods are activated. Under 
normal conditions the cone-rod transformation occurs after 5 minutes whereas in RP 
patients there is delayed cone-rod break (Fitzke, 1994). 
 
1.5.6.6.5 Electro-Oculography 
 
Electro-oculography (EOG) reveals the function of RPE and outer retina. If ERG 
outcome is atypical, EOG will also be abnormal. EOG abnormalities are more 
observed in patients over the age of 40 (Vingolo et al., 2006). 
 
1.5.6.6.6 Optical Coherence Tomography 
 
OCT determines detailed retinal structural changes. It is also used for identification of 
cystoid macular edema (CME) (Hajali et al., 2009) as well as decreased photoreceptor 
thickness along with loss of visual field sensitivity (Rangaswamy et al., 2010). 
 
1.5.6.6.7 Color Vision 
 
The most common color vision test is The Ishihara Color Test for testing color vision 
defects. It was named after a Japanese professor Dr. Shinobu Ishihara who was 
designed and published the test in 1917(S. Ishihara, 1917). This is a series of colored 
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plates called Ishihara plates that contain dots which are not easily distinguished by 
persons with color vision difficulties. 
 
1.5.6.6.8 Electroretinography 
 
Electroretinography is a test for measuring the photoreceptor response to electrical 
stimulation. This test provides commendable information regarding diagnosis and 
classification of RD diseases. The test is conducted by initially numbing the eyes with 
numbing drops to avoid any discomfort. Electrodes are fixed on the cornea of the 
patient’s eyes. The eyes are then subjected to standard electrical stimulation which in 
turn stimulates different retinal cells. The electrical responses are collected on a 
screen, where they can be observed and recorded. In presence of light retinal cells can 
elicit stronger responses. The test is performed again in the dark after allowing 20 
minutes for the eyes to adjust. A normal response produced by different levels of 
retinal illumination at adjacent points show a specific pattern of waves called A 
(caused by photoreceptor cells during phototransduction) and B (produced from 
bipolar cell activity) (Thompson et al., 1987). ERG is useful for accurate diagnosis of 
several retinal diseases such as RP, LCA, ACHM, CD, CSNB and others, for 
assessment of severity to follow the course of disease and provide possible prognosis. 
 
1.6 Therapies 
 
While the diagnosis of retinal dystrophies can be overwhelming for patients, it is 
important to help them protect and maximize the vision they still have. Some 
treatments can prolong vision for an extended period of time and allow patients to 
perform daily tasks with the use of low vision aids. 
 
1.6.1 Electronic Retinal Implants 
 
Electronic retinal devices are implanted into the retina to replace the function of dead 
or degenerated photoreceptor cell by capturing the images and converting them to 
electrical signal. The function of these devices, therefore rely on its efficient 
connection to the viable neurons (Santos et al., 1997, Matsuo et al., 2007). Sub retinal 
implants have potentially restored vision in patients suffering from RP and age related 
macular degeneration to an extent of localization and recognition of objects even 
reading letters (Zrenner et al., 2010). 
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1.6.2 Retinal Transplant 
 
Retinal transplant uses new cells to replace the damaged photoreceptor cells (Comyn 
et al., 2010). Retina serves as a viable substrate for cell based therapies therefore stem 
cells from different tissue sources can be used for transplantation (Jayashree et al., 
2011). 
 
1.6.3 RPE Transplantation 
 
The main goal of Retinal pigment epithelial (RPE) transplantation is to recover the 
interaction between RPE and the photoreceptor, which is the base of visual function. 
Together with the photoreceptor cells, the RPE provide visual perception and 
maintenance of the extra cellular matrix. Several patients underwent RPE transplant 
presented high rate of success in their visual acuity (Radtke et al., 2008). Nonetheless 
a patient with severe loss of photoreceptor cells cannot benefit from this technique. 
 
1.6.4 Gene Therapy 
 
Gene therapy is the use of healthy DNA to restore the functional aspects of a mutated 
gene. The basic principle involves the transfer of a non-mutated edition of the altered 
gene using viral or non-viral vectors into the cells to restore the normal activity of the 
gene. There are two gene therapy methods currently used for the replacement of 
nonfunctional gene, known as, gene augmentation therapy and gene silencing therapy. 
 
1.6.4.1 Gene Augmentation Therapy 
 
Gene augmentation therapy is applied to genetic disorders caused by defective gene 
expression using a carrier vectors such as Adeno-associated virus (AAV) for 
transduction of retinal cells (Lebherz et al., 2008). This therapy has been widely 
studied in Leber’s congenital amaurosis (LCA) with mutation in RPE65 gene. In an 
experimental approach using an RPE65
-/-
 dog suffering from loss of normal vision 
resembling human LCA, surgical delivery of recombinant AAV carrying RPE65
+/+
 
greatly enhanced light sensitivity of the photoreceptor cells (Acland et al., 2001). Till 
date significant number of LCA patients have undergone successful gene therapy for 
RPE65-LCA and gained visual improvement with no major side effects (Artur et al., 
2009). 
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1.6.4.2 Combined Gene-Silencing and Gene Replacement 
 
In certain autosomal dominant cases, toxic gain of function mutations results in either 
a mutated protein or a negative effect of the encoded protein. Two techniques are 
considered for silencing the altered gene: ribozymes and RNA interference (siRNA). 
 
Ribozymes are catalytic RNA molecules that cleave the mRNA thereby silencing the 
genes that produced them. In this case ribozymes can discriminate and cleave the 
mutant mRNA molecules to prevent the production of the mutant rhodopsin (Lewin et 
al., 1998). Hence a drawback of this method is that ribosome therapy is merely 
mutation dependent. 
 
The siRNA on the other hand is a process by which cells control gene expression. It is 
a mutation independent method used for gene silencing. This technique is a 
combination of gene repression in conjunction with gene substitution by which the 
mutant and wild-type alleles are suppressed followed by a codon-modified 
replacement gene refractory. With this approach a 90% success rate was obtained 
from in vivo suppression of RHO in photoreceptors, with use of adeno-associated 
virus (AAV) RHO-replacement gene delivery in Pro23His mice. This technique 
represents a safe and efficient approach of delivering molecular therapies to 
photoreceptors, hence can be used to provide future therapies for patients with RHO-
linked RP and other disorders (Mary O’Reilly et al., 2007). 
 
1.7 Disease Gene Identification Approaches for RP 
 
Disease gene identification is the process of identification of the mutant genotypes 
responsible for inherited disorders. An intensive understanding of the phenotype-
genotype relation relies on the ability to detect and characterize the genes. Several 
approaches can be used to identify the disease causing genes in patients or families 
and are briefly described below; 
 
1.7.1 Candidate Gene Approach 
 
The candidate gene approach focuses on associations between genes of interest and 
disease phenotypes. Candidate genes are selected based on a previous knowledge of 
the gene's known biological, physiological, or functional impact on the disease of 
interest. Once the gene is identified, a number of studies can be conducted on the gene 
and its encoded protein to assess the molecular basis of the inherited disorder. In 2012 
Alejandro Estrada-Cuzcano et al identified a novel gene leading to RP and CRD. 
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Immunohistochemical studies suggested that C8orf37 is localized at the base of 
connecting cilia of mouse photoreceptor cells demonstrating ciliary function. 
 
The candidate gene analysis either involves direct sequencing of the target gene or 
may utilize different types of polymorphic markers to quickly analyze large cohorts. 
Majority of the studies of later type initially employed restriction fragment length 
polymorphism (RFLP) and microsatellite markers but single nucleotide 
polymorphisms (SNPs) are the preferable choice in the current genomic era. The data 
obtained from various types of markers have been utilized for linkage analysis and 
Homozygosity mapping to map the underlying gene in sporadic patients or families 
with inherited disorders. 
 
1.7.2 Linkage Analysis 
 
The main theme of linkage analysis is to study pattern of co-inheritance of marker 
alleles and the absence/presence of a phenotype. This technique benefits from the fact 
that during meiosis two or more genetic loci that are physically close to one another 
are transmitted together on the same chromosome (Richard Twyman, 2003). Both 
parametric and non-parametric models have been applied to map genes responsible 
for monogenic and complex disorders, respectively. The statistical evidence for 
linkage is usually determined by LOD score and a score of 3 or above is considered 
significant. Linkage studies have successfully led to the discovery of genetic loci that 
contribute to the risk of diseases or variation of quantitative traits (Bailey-Wilson et 
al., 2011). Implication of Linkage analysis determined presence of two different 
USH1 loci on chromosome 1 and localization of an ADRP gene on chromosome 17p 
(Smith et al., 1992; Greenberg et al., 1994). 
 
1.7.3 Homozygosity Mapping 
 
Homozygosity mapping is a powerful technique for detection of autosomal recessive 
mutations in small inbred populations with high incidence of consanguineous 
marriages among close relatives (Zhang et al., 2011) as consanguineous marriages 
provide rich source of suitable families for this approach. Small chromosomal regions 
are transmitted consecutively thus affected individuals will show homozygosity by 
decent in the vicinity of the disease locus. Homozygosity mapping benefits from the 
likelihood that affected individuals carry two recessive copies of the defective allele 
from a common ancestral source (Zobor et al., 2014). Homozygosity mapping and 
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linkage analysis mapped RP22 to the short arm of chromosome 16 (Finckh et al., 
1998). 
 
1.7.4 High Throughput Analysis 
 
In the post genomic era substantial progress has been made to introduce, implement 
and improve high throughput applications to quickly find disease gene including RP. 
This progress resulted initially due to the development of dense single nucleotide 
polymorphisms (SNPs) arrays and later by the introduction of next generation DNA 
sequencing. SNP genotyping analyzed 22 arRP and LCA genes in a single and 
efficient genotyping to reveal CERKL as the causative RP gene (Pomares et al., 2007). 
 
 
Copy number of variations (CNVs) are defined as genomic variations with alternate 
copy number as compared to reference genome sequence (Redon et al., 2006) and are 
occasionally associated with disease phenotypes in humans (Clancy, 2008). In 2011 
Esther Pomares et al., identified six novel CNV mutations leading to RP, which 
indicate the involvement of additional genomic regions in RP and other eye related 
disorders. 
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Table 1.1 Genes and Loci for LCA 
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Table 1.2 Genes and loci for Retinitis Pigmentosa 
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1.8 Aims & Objection 
 
The overall purpose of the study is to identify and characterize the underlying 
variations in the affected individuals of eight Pakistani families, but specific aims are; 
 
1. Identification, clinical evaluation and recruitment of large consanguineous 
families with multiple patients presenting autosomal recessive retinitis 
pigmentosa.  
 
2. Homozygosity mapping and linkage analysis will be employed on the 
genotype data generated with genome-wide SNP arrays to identify disease 
gene containing homozygous regions in collected families. The known RP 
genes mapped in these families will be subjected to Sanger sequencing to 
identify underling pathogenic variants.  
 
3. Next Generation Sequencing will be used to identify the disease causing 
mutations in families negative for known RP genes.  
 
4. The identified variants will be further characterized to explore the effects of 
mutations and to understand the pathogenic mechanisms responsible for vision 
loss in the studied families.  
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MATERIALS AND METHODS 
 
2.1 Field Work 
 
This study was conducted to investigate the genetic basis of autosomal recessive 
retinitis pigmentosa (RP) in the Pakistani families. For this purpose, eight families 
with multiple members presenting impaired vision were identified from various rural 
populations of Pakistan. These families were initially identified through field surveys 
of the respective areas, but only prospective families were selected for further genetic 
analysis by following the ethical approvals obtained from the Quaid-i-Azam 
University institutional board. Infomred consent was obtaind from all families. 
 
The specific details on family enrolment and sample collection are given below. 
 
2.1.1 Family Enrollment 
 
During field visits information such as disease history, nature of relationship among 
the couples, number of children, age of onset of vision loss, prevalence of disease in 
the family and mode of inheritance were collected and carefully recorded. Relevant 
findings in family members were documented through their medical examinations. 
Ophthalmic history, associated with RP and other related retinal dystrophies (RD), 
was established to determine the cause of disease in respective individuals of each 
family. For this study, we selected families with convincing evidence that disease 
phenotype is present in multiple (Two or more) individuals and follow autosomal 
recessive mode of inheritance. Pedigrees were drawn based on interviews with 
multiple family members. The squares and circles in the pedigree are respectively 
assigned to male and female members. Filled symbols indicate affected individuals 
while clear symbols represent normal individuals. Consanguineous marriages are 
depicted by double lines and deceased are depicted by slant lines. 
 
2.1.2 Blood Sample Collection 
 
The venous blood sample (10ml) was collected in the standard ethylene diamine tetra 
acetate (EDTA) vacutainer tubes (BD vacutainer K3-EDTA, Franklin Lakes) for each 
affected individual and the available participating healthy individuals from each fami-
ly. These collected blood samples were properly coded and maintained at 4˚C until 
DNA extraction. 
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2.1.3 Clinical Evaluations 
 
Complete medical history was obtained from all members of the enrolled families to 
ensure the presence or absence of other related or non-related disorders. Initially 
affected members from each family were questioned about their visual problems to 
record variations in the age of onset, extent of visual field (if present), status of the 
current vision and severity of the vision loss. Later these individuals were evaluated 
by an ophthalmologist at nearby local hospitals to test visual acuity, color vision, 
nystagmus, cataract, refractive index and fundus. Patients with advanced stages 
underwent light perceptive (LP) and finger count (FC) evaluations to determine the 
extent of their vision loss. When possible, digital fundoscopy was performed on the 
proband from these families to document the underlying retinal changes. Similarly 
fluorescent angiography (FAG) was also performed in a proband to identify the nature 
of the retina and choroid. All data collected from families was safely stored for easy 
access if required in the future. 
 
2.2 Laboratory Evaluations 
 
2.2.1 DNA Extraction 
 
Standard phenol-chloroform extraction method also known as 'organic method' was 
used to extract the total genomic DNA from the blood of all members. 
 
In a 1.5 ml eppendorf tube, 750 μl of blood was completely mixed with equal volume 
of solution A and incubated at room temperature for 10-15 minutes and centrifuged at 
13000 RPM (Eppendorf, Model 5417C, Germany) for 1 minute. Without disturbing 
the pellet, the supernatant was discarded and the pellet was re-suspended in 400 μL of 
solution A and centrifuged for 1 minute at 13000 RPM. Supernatant was carefully 
discarded and pellet was re-suspended in 500 μL of solution B, 12 μL of 20% SDS 
and 20 μL of proteinase K (20 mg/mL) and incubated overnight at 37˚C. On the next 
day a freshly prepared mixture of 500 μL phenol and solution C was included in the 
overnight mixture and centrifuged for 10 minutes at 13,000 RPM. Upon centrifuga-
tion two distinct phases were obtained, but the upper aqueous phase was carefully 
transferred to a new tube followed by the addition of equal volume of solution C and 
centrifugation at 13000 RPM for 10 minutes. Again the aqueous phase was collected 
in a fresh 1.5 ml tube and the genomic DNA was precipitated by adding 55 μL 3M 
sodium acetate (pH 6) and equal volume (500 μL) of isopropanol. Tubes were invert- 
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ed several times and centrifuge again for 10 minutes at 13000 RPM to obtain a DNA 
pellet. The supernatant was discarded and to the pellet 200 μL of chilled 70% ethanol 
was added and centrifuged again at 13000 RPM for 7 minutes. This time supernatant 
was cautiously discarded, and the pellet was left to dry in an incubator (Model B28, 
Binder Germany) for 15-20 minutes before finally dissolved in 150-200 μL of Tris-
EDTA (TE) buffer. 
 
2.2.1.1 Solutions 
 
Solution A: Sucrose 0.32 M, MgCl2 5 mM, Tris (pH 7.5) 10mM, Triton X-100 1% 
(v/v) 
 
Solution B: Tris (pH 7.5) 10mM, EDTA (pH 8.0) 2mM, NaCl 400 mM 
 
Solution C: Chloroform 24 volumes, Isoamyl alcohol 1 volume 
 
Buffer for Dissolution of DNA (TE): Tris (pH 8) 10 mM, EDTA 0.1 mM 
 
2.2.1.2 DNA Quantification 
 
DNA concentration was determined using 1 µl of the DNA sample and measuring op-
tical density (OD) at 260 nm and 280 nm (Nanodrop 3300, Thermo scientific, USA). 
However, the integrity of the extracted DNA samples was determined by 1% agarose 
(0.5 g of agarose added to 50 ml of 1X TBE; 0.89M Tris-Borate, 0.032M EDTA) gel. 
DNA samples with higher concentration and intact bands on agarose gels were further 
diluted with TE or nuclease free water for subsequent genetic analysis. 
 
2.2.2 Homozygosity Mapping 
 
Homozygosity mapping is a useful approach for the analysis of inherited disorders, 
predominantly in the consanguineous families with multiple affected members. For 
this reason available members of eight families enrolled in this study, were initially 
genotyped for microsatellite markers spanning the genomic regions with RP 
genes/loci (Table 2.1) already reported to be common in Pakistan. Physical locations 
of the microsatellite markers flanking these genes/loci were obtained from UCSC ge-
nome browser (http://genome.ucsc.edu/) (build hg19). The STS markers flanking the 
known genes were PCR amplified from the available DNA samples of each family 
and the products were separated on 8% non-denaturing polyacrylamide gel (as de-
scribed below) to determine the genotypes. The genotype data obtained for four to 
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five STS markers was analyzed to find the presence or absence of homozygous ge-
nomic regions around a known RP gene in each family. 
 
Later these families were subjected to high density genome scan to map the disease 
gene containing homozygous genomic regions. Whole-genome scan was performed 
using either Gene Chip Human Mapping 250K-Nsp SNP array (Affymetrix, Santa 
Clara, CA) or Infinium® HumanCoreExome BeadChip (Illumina, USA), which con-
tain approximately 250,000 and 500,000 markers, respectively. These experiments 
were carried out either at MFT Services University of Tubingen, Germany or De-
partment of Genome Sciences, University of Washington, USA. 
 
2.2.2.1 Microsatellite Marker Genotyping 
 
DNA samples from available members of all families were used to amplify the 
markers flanking known genes (Table 2.1) and PCR products were resolved on 8% 
non-denaturing polyacrylamide gel. For this purpose, prepared gel solution (section 
2.2.2.1.1) was poured between two glass plates maintained at a distance of 1.5 mm 
from each other. The solution was left to polymerize at room temperature and fixed 
onto the V16-2 vertical gel tank (Life Technologies, USA). Prior to loading in the gel, 
5 µl of the loading dye (0.25% bromophenol blue with 40% sucrose) was added to the 
PCR products. Electrophoresis was carried out for 2 hours at 120 volts. The gel was 
stained by soaking in an ethidium bromide solution (0.5μg/mL) for 1 minute and was 
placed in the Gel Doc (SYNGENE, UK) to document and analyze the resulting band-
ing pattern of the normal and affected individuals of each family. This procedure was 
repeated for all markers listed in table 2.1 and homozygosity was confirmed when all 
affected members of a family have a similar size band for multiple markers used for 
respective RP gene. 
 
2.2.2.1.1 Preparation of 8% Polyacrylamide Gel 
 
30% Acrylamide solution (29 g polyacrylamide, 1 g NN’-Methylene bis acryla- 
 
mide): 13.5 mL 
 
TEMED (N, N, N’, N’-Tetra Methyl Ethylene Diamine): 17.5 μl 
 
10 % Ammonium persulphate (APS): 350 μl 
 
10X TBE buffer: 5 ml 
 
Distilled water: 31.13 ml 
 
Linkage Analysis of Pakistani Families with Autosomal Recessive Retinitis Pigmentosa 29 
Chapter 2 Materials & Methods 
 
 
2.2.2.2 SNP Genotyping by Microarray 
 
In order to maintain a cost effective strategy initially DNA samples of available 
affected members of families A, E, F G and H were selected for high throughput 
genotyping. However for family C, one normal member was also selected along with 
affected individuals for high density SNP genotyping. In contrast all available mem-
bers of family D underwent a genome scan using the Infinium® HumanCoreExome 
BeadChip (Illumina, USA) 500K array, by following the manufacturer recommended 
protocol. Overview of the Nsp chip assay used for remaining families is depicted in 
Figure 2.1. 
 
DNA samples with 50ng/µl concentration (Total 3ug conc.) from the selected indi-
viduals were used for genome scan. For each selected sample, 5 µl of DNA was treat-
ed by Nsp restriction endonuclease (Table 2.2) and placed in the thermal cycler (Ge-
neAmp® PCR System 9700 Applied Biosystems) at 37 ˚C for 120 minutes and 65 ºC 
for 20 minutes. Later 20 µl of the digested DNA was taken for ligation using Nsp 
adaptors (Table 2.2). Samples were placed in thermal cycler at 16 º for 180 minutes 
and 70 ºC for 20 minutes. After the completion of 250K ligation program 25 µl of the 
ligated DNA was combined with 75 μL water (AccuGENE®, Germany) and under-
went PCR using primers and TITANIUM Taq DNA Polymerase (50X) (Takara, Clon-
tech) (Table 2.2). PCR was carried out with initial denaturation at 94 ºC for 3 minutes 
(1 cycle), following 30 cycles at 94 ºC for 30 seconds, 60 ºC for 45 seconds and 68 ºC 
for 15 seconds, 1 cycle of extension at 68 ºC for 7 minutes and a halting temperature 
of 4 ºC. To ensure consistent results, 3µl of the PCR products were loaded on to a 2% 
Tris/Borate/EDTA (TBE) gel and allowed to run at 120 V for 1 hour (DNA fragments 
should vary between 250 bp to 1100 bp). The next step was to purify the PCR prod-
ucts as mentioned in table 2.3. After the wash, wells were completely dried, quanti-
fied and normalized to obtain a 2 μg/μl DNA concentration in RB buffer for subse-
quent fragmentation as mentioned in table 2.4. These were placed in thermal cycler 
following 37 ºC for 35 minutes, 95 ºC for 15 minutes and 4 ºC hold. Products were 
loaded onto a 4% TBE gel and allowed to run at 120 V for 50 minutes to select frag-
ments with size less than 180. The subsequent step includes labelling of the fragment-
ed DNA for which 50.5 µl of the fragmented DNA is required (Table 2.4). The sam-
ples are kept in the thermal cycler again under conditions of 37 ºC for 4 hours, 95 ºC 
for 15 minutes and a final 4 ºC arrest. Next a hybridization master mix is prepared 
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(Table 2.4) and added to 70 µl of the labelled DNA samples and again placed in ther-
mal cycler to undergo denaturation at 95 ºC for 10 minutes and 49 ºC arrest. Finally 
the arrays are loaded on to the hybridization chip (GeneChip® Human Mapping 250K 
Nsp) and placed into the hybridization oven that was preheated to 49 °C and left to 
hybridize at 60 RPM rotation for 16 to 18 hours. Next day, the hybridization cocktail 
was removed from the probe array collected in a 1.5ml vial and stored on ice using a 
three step process including Streptavidin Phycoerythrin (SAPE) stain for which stain-
ing reagent was prepared (Table 2.5) and combined with Streptavidin Phycoerythrin 
(SAPE) (Table 2.5) followed by antibody amplification (Table 2.5) and SAPE stain-
ing. Following the last staining the array is filled with array holding buffer (Table 2.6) 
and carefully washed with buffers A and B to avoid bubble formation. Finally the 
probe array were scanned on the GeneChip® Scanner 3000 7G using the GCOS 
Software 1.4 (Affymetrix, USA). 
 
2.2.2.2.1 Microarray Reagent Preparation Protocol 
 
12X MES Stock Buffer (pH 6.5-6.7) 
 
 (1.25 M MES, 0.89 M [Na+]) For 1,000 mL 

 70.4g of MES hydrate 

 193.3g of MES Sodium Salt 

 800 mL of Molecular Biology Grade Water 

 Mix and adjust volume to 1,000 mL and filter through a 0.2 μm filter 
 
Wash A: Non-Stringent Wash Buffer 
 
 (6X SSPE, 0.01% Tween 20) For 1000 mL: 

 300 mL of 20X SSPE 

 mL of 10% Tween-20 

 699 mL of water 

 Filter through a 0.2 μm filter and store at room temperature 
 
Wash B: Stringent Wash Buffer (pH 8.0) 
 
 (0.6X SSPE, 0.01% Tween 20) For 1000 mL 

 30 mL of 20X SSPE 

 mL of 10% Tween-20 
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 969 mL of water 

 Filter through a 0.2 μm filter and store at room temperature 
 
2.2.3 Data Analysis 
 
The obtained results were analyzed by Homozygositymapper 
(http://www.homozygositymapper.org/) to determine homozygosity by decent (HBD) 
regions shared among affected individuals (Seelow et al., 2009). In these families au-
tozygous regions in the genome were identified by using the genotypes only from af-
fected individuals except C and D families. For these two families genotypes from 
normal individuals were also included in the analysis. The data were analyzed by se-
lecting genetic homogeneity and 250 block length limit. The flanking boundaries and 
respective SNPs were detected for each family to enlist identified homozygous re-
gions. 
 
For each family the identified genomic regions were further analyzed with 
GeneDistiller (Seelow et al., 2008). By selecting the Eye/Vision phenotype option of 
GeneDistiller, a list of genes related to the eye phenotypes were obtained and candi-
date genes related to the retinal dystrophies mapped within the homozygous regions 
were selected for Sanger sequencing in the respective families. 
 
2.2.3.1 Linkage Analysis 
 
Parametric linkage analysis was carried out using Easylinkage plus v5.02 software 
(Hoffmann and Lindner, 2005) for genotype data obtained for all STS markers and 
the genome wide SNP markers from selected genomic regions. Two-point and 
multipoint LOD scores were calculated by using Fastlink v4.1 (Lindner and 
Hoffmann, 2005) and Merlin v1.0.0 (Abecasis, et al. 2002) respectively. These 
analyses were performed by using equal marker allele frequency, disease frequency of 
0.001 and sex average map distances from Marshfield STRP map. 
 
2.2.4 Sanger Sequencing 
 
To identify the disease causing mutation, Sanger sequencing was performed in 
families mapped to the known RP or RD genes. Initially proband from each mapped 
family was used to sequence the coding exons and flanking splice sites to identify the 
causal mutation, which was later tested in the complete family to confirm the 
segregation with the disease phenotype. The details are as followed; 
 
Linkage Analysis of Pakistani Families with Autosomal Recessive Retinitis Pigmentosa 32 
Chapter 2 Materials & Methods 
 
 
2.2.4.1 Primer Design and PCR amplification 
 
Primers  for  all  coding,  non-coding  exons  and  flanking  introns  of  ZNF513 
 
(NM_144631.5), C2ORF71 (NM_001029883.2), VSNL1 (NM_003385.4), FAM161A 
 
(NM_001201543.1), CLN3 (NM_001286109.1), C8ORF37 (NM_177965.3), LCA5 
 
(NM_181714.3), NMNAT1 (NM_001297778.1) and genes were designed using Pri-
mer3plus (http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi/) and 
were checked through in-silico PCR and BLAT tool from UCSC Genome Browser 
(http://genome.ucsc.edu/). Table 2.7-2.16 represents the primers used for the amplifi-
cation of target region by using procedures described in section 2.2.4.2. 
 
2.2.4.2 PCR 
 
PCR reactions were carried out using microsatellite markers mentioned in table 2.1 
and primers listed in tables 2.7-2.16. A 25 µl reaction mixture was prepared in 0.2 mL 
PCR tubes (Axygen, USA) containing 2.5 μL 10 X buffer (100 mM Tris-HCl, pH 8.3, 
500 mM KCl), 1.5 μL MgCl2 (25 mM), 0.5 μL dNTPs (10 mM, Fermentas, UK), 0.3 
 
μL of each forward and reverse primer (10 pM), 2 μL DNA sample (50 ng), 0.2 μL 
Taq DNA polymerase (5 U/μl, Ferrmentas, UK) and required amount of dH2O. 
 
DNA samples were amplified in T1 thermal cycler (Biometra, Germany) using stand-
ard PCR following preheating of template DNA at 95˚C for 5 minutes, denaturation at 
 
95˚C for 1 minute, annealing temperatures ranging between 54-58 ˚C for 1 minute, 
initial extension at 72˚C for 1 minute and final elongation at 72˚C for 10 minutes. 
Usually 40 cycles were used to complete the amplification reaction. 
 
For  amplification  of  large  genomic  fragments  (≥1  kb),  Long  PCR  Enzyme  Mix 
 
(Fischer Scientific, Germany) was utilized according to manufacturer's instructions. 
 
2.2.4.3 PCR Product Purification 
 
The amplified PCR products were purified with ExoSAP IT (GE Healthcare, Frei-
burg, Germany) and then used for sequencing PCR. The ExoSAP reaction was con-
ducted by taking 1µl of the PCR product in 0.2 ml PCR tube and 5 µl of diluted Ex-
oSAP (1:20 dilution) followed by incubation in a thermal cycler at 37 ºC for 15 
minutes and 80 ºC for another 15 minutes to deactivate the enzyme. 
 
For some specific genes, larger PCR products were purified from 1% agarose gel 
before proceeding for the Sanger sequencing. The gel was sliced with a clean and 
 
Linkage Analysis of Pakistani Families with Autosomal Recessive Retinitis Pigmentosa 33 
Chapter 2 Materials & Methods 
 
 
sharp scalp to obtain slices with required PCR products and were purified with 
QIAquick Gel Extraction Kit (Qiagen, Germany). According to the weight of the gels 
three volumes of GQ buffer was added to the 2 ml eppendorf tubes per one volume of 
the gel and incubated at 50°C for 10 min. Once the gel dissolved, 1 gel volume of 
isopropanol was added to the sample and mixed. The samples were then applied to the 
QIAquick column, and centrifuged (Sigma 1-14K, Germany, GmbH) at 13,000 RPM 
for 1 min. The flow-through was discarded and the collection tubes were re-used by 
placing the QIAquick column back in the same collection tube. To the column 0.5 ml 
of Buffer QG was added and centrifuged at 13,000 RPM for 1 minutes to remove all 
traces of agarose. The washing step was carried out after the flow-through was 
discarded and 0.75 ml of Buffer PE was added to the QIAquick column and again 
centrifuged for 1 minute. The flow thorough was discarded again and this time the 
column was spun empty for 1 minute to fully remove the residual ethanol from Buffer 
PE. Finally the QIAquick column was placed into a clean 1.5 ml microcentrifuge tube 
and to elute DNA, 50 µl of EB buffer was added right in the center of the column 
membrane and spun for 2 minutes at 13,000 RPM. DNA was collected at the bottom 
of the tube and measured by using nanodrop (Thermo scientific, USA) to determine 
the extraction yield. 
 
2.2.4.4 DNA Sequencing 
 
Both types of purified PCR products were subsequently subjected to DNA 
sequencing, by applying 1µL of BigDye Terminator 1.1 (Applied Biosystems, 
Darmstadt, Germany), 2 µl of 5X Big Dye Buffer (Applied Biosystems, Darmstadt, 
Germany) and 0.4 µl of Forward or Reverse primer (10 pmol/µl). Cycling conditions 
consisted of initial denaturation at 96 ºC for 2 minutes followed by 25 cycles of dena-
turation at 96 ºC for 15 seconds, annealing at 55 ºC for 15 seconds and an extension 
of 4 minutes at 60 ºC and finally stopped and maintained at 8 ºC. 
 
After completion of the cycles, each sample was precipitated with a mixture consist-
ing of dH2O (10ul), 125mM EDTA (5ul) and 100% Ethanol (75ul) and centrifugation 
(Sigma 4K10, Germany) at 20 ºC for 30 minutes at 5000 RPM. After centrifugation 
the tubes were opened and while covering them with tissue paper, they were inverted 
and centrifuged at 1244 RPM for 1 minute. This step allowed the solution to pour out 
from the tube. To the empty tubes 60 µl of 80% ethanol was added and centrifugation 
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was repeated at 20 ºC for 20 minutes at 3714 RPM. In order to discard the ethanol, a 
short centrifugation was carried out as mentioned above. 
 
Finally all samples were run on the ABI 3130X DNA sequencer, processed with the 
Sequence Analysis 5.1 software (Applied Biosystems) and aligned with the reference 
sequence from human genome reference hg19 by applying DNA STAR Seqman 
software package (Lasergene, Madison WI, USA). 
 
2.2.5 DNA Walking 
 
DNA walking strategy was used to identify and characterize the large genomic 
deletion in LCA5 gene. Based on the PCR and gel electrophoresis results, primers 
were designed to carry out DNA walking (Cullen et al., 2011) in family E by using 
APAgene™ GOLD Genome Walking Kit (BIO S&T, Canada). 
 
For this purpose three gene specific primers (GSPs) were designed using Primer3 
(Table 2.17) and PCR based DNA walking was performed to identify the deletion 
breakpoints. In the primary PCR single stranded DNA fragments were produced using 
GSPa in four individual tubes to which the four different DRT primers were added. 
During the first nested PCR, GSPb was included along with the universal tagging 
primer. The UAP-N1 reduces the formation of non-specific amplifications. In the sec-
ond nested PCR, GSPc along with UAP-N2 were added to increase the yield of the 
product required for sequencing or cloning (Figure 2.2). 
 
2.2.6 Functional Minigene Analysis 
 
In order to evaluate the effect of a splice variant identified in the C8ORF37 gene, a 
functional mini gene assay was conducted. The DNA fragment of the C8ORF37 gene 
consisting of exons 2, 3 and 4 was sub cloned into the pSPL3 vector by using 
modified primers (Table 2.17). The 5' of forward primer and 3' of reverse primer 
contains extra sequences for Not I (GCGGCCGC) and BamH1 (GGATCC) restriction 
enzymes, respectively. The restriction site sequences of both primers were further 
flanked by 6-8 bps of 'AT' sequences (Table 2.17) and long distance PCR using Long 
PCR Enzyme Mix (Fischer Scientific, Germany) was performed to amplify the target 
region by following manufacturer protocol. PCR product was purified using 
QIAquick PCR Puri-fication Kit (Qiagen, Germany). The specific procedure is 
depicted in figure 2.3 and the details are described below; 
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2.2.6.1 Restriction Enzyme Digestion and Fragment Purification 
 
Restriction enzyme digestion was conducted on purified PCR products obtained from 
a affected and a control sample of C family. A total of 100 µl reaction mixture was 
prepared (shown below) and incubated at 37 °C overnight followed by purification 
using QIAquick PCR Purification Kit (Qiagen- Germany). 
 
73 µl of PCR product 
 
10 µl of 10X Bovine Serum Albumin (BSA) (Fischer Scientific, Germany) 
 
10 µl of 10X Buffer O (Fermentas, Germany) 
 
1 µl of (1 unit) Not I restriction enzyme (Fermentas, Germany) 
 
1 µl of (1 unit) BamH I restriction enzyme (Fermentas, Germany) 
 
5 µl of dH2O 
 
Similar procedure was performed on 2 µg of vector (2 µl) in a 50 µl reaction volume 
and DNA fragments were purified by using QIAquick PCR Purification Kit (Qiagen, 
Germany). The procedure begins by adding 5 volumes of buffer PB to 1 volume of 
PCR product or enzymatic reaction and the samples were applied to QIAquick col-
umn and centrifuged (Sigma 1-14K) for 1 minute at 13,000 RPM. The supernatant 
was discarded and the column was placed back into the same tube. Subsequently these 
samples were purified as already described in section 2.2.4.3. 
 
2.2.6.2 Ligation with T4 DNA Ligase 
 
The purified vector and insert were treated with T4 DNA ligase (NEW ENGLAND 
Biolabs, Germany) to promote their ligation. A 20 µl reaction consisting of 2 μl of 
10X T4 DNA Ligase Buffer, 50 ng (2 µl) of vector DNA, 50 ng (1 µl) of insert DNA, 
1 µl if T4 DNA Ligase and 14 µl of dH2O was prepared and incubated for 2 hours at 
room temperature. 
 
2.2.6.3 Transformation of NEB 10-beta Competent E.coli Cells 
 
The tubes containing NEB 10-beta competent E.coli cells were thawed while kept on 
ice, gently mixed and 45µl of the cells were transferred into a 1.5 ml tube on ice 
congaing 5 µl of the ligation reaction. The mixture was incubated on ice for 30 
minutes followed by a 30 second heat shock at 42 °C. Immediately after 30 seconds, 
the sample was placed on ice for 5 minutes. Later 950 µl of SOC (Super Optimal  
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Broth) medium (Invitrogen™) was added to increase the transformation efficiency 
and sample was incubated at 37 °C for 1 hour in the shaker (Thermo SCIENTIFIC, 
USA) at 300 RPM. After incubation two agar plates were taken. On the first plate 100 
µl of the transformation mixture was spread while the remaining 900 µl was spun 
(Sigma 1-14K) for 5 minutes at 5000 RPM. 800µls of the mixture was discarded 
while the remaining 100 µl was mixed again with the pellet by flicking at the bottom 
of the tube and spread on to the surface of the second agar plate. The plates were in-
cubated at 29 °C for 48 hours. 
 
2.2.6.3.1 Preparation of LB (Luria-Bertani) Medium and LB Agar- 
 
Plates 
 
 LB-medium (1 L): 
 
10 g of tryptone, 5 g of yeast extract, and 10 g NaCl were dissolved in 950 mL 
deionized water. The pH was adjusted to 7.0 using 1M NaOH. Antibiotic can be 
added upon requirement. (50µg / mL of Amp or Kan). 
 
 LB agar-plates: 
 
To the LB medium add 15 g/L of agar and autoclave. Allow the medium to cool down 
and add 600 µl of Ampicillin (Life Technologies, Darmstadt, Germany) and pour into 
the petri dishes. 
 
2.2.6.3.2 Super Optimal Broth (SOC) Composition 
 
To obtain maximum transformation efficiency of E. coli, SOC medium is added. 
 
 2% tryptone 

 0.5% yeast extract 

 10 mM NaCl 

 2.5 mM KCl 

 10 mM MgCl2 

 10 mM MgSO4 

 20 mM glucose. 
 
2.2.6.4 Colony Selection and Mini Prep 
 
From the agar plates, optimal clones (big single clones that were not surrounded by 
satellites) were chosen and labelled at the back of the petri dish. The selected 
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colonies were picked, simultaneously dipped into the tubes and were subsequently 
dapped on to a new agar plate to generate backups. Each colony was labelled 
accordingly and stored at 4 °C. 
 
The reaction mixture containing the colonies was brought to 50 µl by adding 5 µl of 
10X Amplitaq buffer, 2 µl of 5 mM dNTP, 1 µl of each forward and reverse primer 
(10 pmol/µl), 0.2 µl Taq polymerase ( 5 Units/ µl) and 0.8 µl of dH2O. The samples 
were amplified following the cycling conditions of 60 °C for 20 minutes, 96 °C for 4 
minutes followed by 25 cycles of 60 °C for 20 seconds, 58 °C for 30 seconds 72 °C 
for 1 min/kb, 72 °C for 5 minutes and finally stopped at 4 °C. PCR products were 
checked on 1% TBE gel. 
 
Depending on the number of colonies to be screened, 15 ml falcon tubes (Fischer Sci-
entific, Germany) are prepared by pouring 5 ml of LB medium. Subsequently 7.5 µl 
(1.5 µl/ ml) of Ampicillin antibiotic (Life Technologies, Germany) was added. From 
the back up plates, colonies showing better results on the gel, were picked up with a 
pipette tip and dipped into the medium. Pipetting was done several times to ensure 
complete entrance of the colony into the medium. Tips were immediately discarded. 
Samples were incubated at 37 °C for 16 hours while shaking at 200 RPM. 
 
2.2.6.5 Plasmid DNA Purification and Sequencing 
 
The overnight incubation of E.coli cultures in 5 ml LB medium produces 15 - 25 μg 
plasmid DNA. The peqGOLD plasmid Miniprep Kit (PEQLab Biotechnologie, Erlan-
gen, Germany) was used to get high yield of plasmid DNA by following the protocol 
included with the kit. To collect the bacterial pellet, falcon tubes were centrifuged for 
1 minute at 13,000 RPM (Sigma 4K10, Rotor 11144) and the supernatant was 
discarded. Later 250 μl of Solution I/RNase A was added to the bacterial pellet and 
cells were fully resuspended by vortexing (SciQuip). A clear lysate was further 
obtained by adding 250 μl Solution II and tubes were gently inverted 6-10 times. 
After a 2 minute incubation at room temperature, 350 µl of Solution III was added to 
the clear lysate and gently mixed until a white precipitate was formed followed by 
centrifugation at 13,000 RPM for 10 minutes. Without disrupting the pellet, the clear 
supernatant was transferred to a fresh Perfect Bind DNA column and spun again. The 
flow-through was discarded and the collection tubes were reused. To remove any 
protein contamination the samples were washed with 500 μl PW Plasmid Buffer and 
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centrifuged for 1 min at 13,000 RPM. A second wash was performed with 750 μl of 
DNA Wash Buffer and centrifuged. The flow-through was discarded and the Perfect 
Bind DNA Column was centrifuged to confirm the complete removal of ethanol from 
the wash buffer. In the end the Perfect Bind DNA column was placed into a fresh 1.5 
ml tube and 50 µl of elution buffer was placed in the center of the membrane. 
Samples were centrifuged for 1 minute at 10,000 RPM to get purified plasmid DNA. 
 
The sequencing protocol for plasmid DNA required 2 µl of BigDye1.1 (Applied 
Biosystems, Darmstadt, Germany), 4 µl of 5X BigDye buffer (Applied Biosystems, 
Darmstadt, Germany), 0.5 µl of each forward and reverse primers (10 pmol/ µl) and 
13 µl of dH2O. Cycling conditions are as mentioned in section 2.2.4.4. PCR was 
followed by adding 80 µl of 75% isopropanol to the samples and centrifugation 
(Sigma 4K10, Rotor 11144) of 30 minutes at 4642 RPM, 20 °C and a short spin with 
inverted tubes to discard isopropanol. The samples were further sequenced for analy-
sis of the results. 
 
2.2.6.6 In-vitro-Mutagenesis (IVM) 
 
IVM was performed to determine the effect of splice site variation in C8ORF37 gene. 
Site-directed mutagenesis was used to create specific change in the DNA sequence by 
using oligonucleotide primers (Table 2.17) specific for the wild type allele. 
 
The PCR reaction mixture was prepared using 100 ng of plasmid (bearing the muta-
tion), 1.25 µl of each primer (10 pmol/ µl), 2µl of dNTPs (5 mM), 1 µl of Pfu Ultra II 
polymerase (5 Units/ µl) and 39 µl of dH2O. Samples were placed in the thermal cy-
cler (GeneAmp® PCR System 9700-Applied Biosystems) under the cycling condi-
tions of 95 °C for 1minute, 15 cycles of 95 °C or 30 seconds, 60 °C for 1 minute and 
68 °C for 6 minutes followed 1 cycle at 68 °C for 10 minutes and a final stop tem-
perature at 8 °C forever. 10 µl of the PCR products were run 1% TBE gel. Upon de-
tection of bands to the remaining PCR products 1 µl of Dpn I (10 Units/ µl) was add-
ed and incubated for 1 hour at 37 °C followed by loading another 10 µl of the reaction 
on the 1% TBE gel to check for presence of bands. The samples were subsequently 
sequenced to identify the non-mutant (wild type) cells and further followed the same 
procedures as the mutant type DNA. 
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2.2.6.7 Transfection of HEK Cells 
 
After obtaining the potential population of non-mutant (wild type) and mutant cells of 
C8ORF37 gene, they were transfected into HEK293 cells with the following steps: 
 
To the DMEM medium (Gibco®- Life Technologies, Germany) 50 ml Fetal calf se-
rum (FCS) (Gibco®- Life Technologies, Germany), 5 ml Pen/ Strip (SIGMA- AL-
DRICH) and 5 µl Amphotericin B also called as Fungizone (Gibco®- Life Technolo-
gies, Germany) were added. 1.5 ml of HEK 293 cells were cultured in 25 ml of 
DMEM medium. Fully confluent cells were aspirated and cells were washed with 10 
ml phosphate buffer saline (PBS). PBS was aspirated and 2 ml of 1X Trypsin/ EDTA 
(0.05%) (Gibco®- Life Technologies, Germany) was added followed by incubation of 
cells at 37 °C until cells detach. Trypsin reaction was stopped by addition of 13 ml 
DMEM+ (DMEM with Pen/ Strip and Fungizone). The medium was centrifuged 
(Sigma 4K10, Rotor 11144) at 1500 RPM for 5 minutes followed by aspiration of the 
medium and re-suspension of pellet in 4 ml DMEM- (DMEM without Pen/ Strip and 
Fungizone). To the 6 well cell culture plates (SIGMA- ALDRICH) 2 ml DMEM- was 
added. The plates were labelled as 200 µl, 250 µl and 300 µl according to the quantity 
of the cell suspension that were added to each well. Plate was incubated (Thermo Sci-
entific) overnight at 37 °C. The following day cells were observed under the inverted 
microscope (CKX41, Olympus) to select cells with higher confluence rate. 
 
Transfection was carried out using 4 µg of each wild type and mutant type plasmids 
transferred into individual 1.5 tubes and diluted with 250 µl of Opti-MEM® (Life 
Technologies, Germany). In a separate tube 20 µl of Lipofectamine® (Life Technolo-
gies, Germany) was diluted with 230 µl of Opti-MEM® (Life Technologies, Germa-
ny) and incubated for 5 minutes at room temperature. After incubation both mixes 
were combined and further incubated for 20 minutes followed by transfer of the trans-
fection mix into the wells containing selected HEK 293 cells and again incubated for 
another 6 hours. After incubation the medium was aspirated and 2.5 ml of DMEM+ 
was replaced in the wells and incubated for 24 hours. 
 
2.2.6.8 Total RNA Isolation from HEK cells and DNase Digestion 
 
Medium was removed from cells and 400 µl of lysis buffer was added to the wells. 
The lysate was collected and transferred to DNA removing columns (PEQLAB Bio-
technologie, GmbH) using filter tips. Samples were centrifuged for 1 minute at 10,000 
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RPM. To the flow-through 400 µl of ethanol was added and thoroughly mixed. 750 µl 
of the mixtures were transferred to Perfect Bind RNA columns and centrifuged again. 
The flow-thorough was discarded along with the collection tube and the column was 
subsequently placed into a clean collection tube. 500 µl of wash buffer I was added 
and sample was centrifuged at 9000 RPM for 15 minutes. Flow-through was discard-
ed again and to the column 600 µl of wash buffer II was added. Centrifugation was 
performed using the previous program and wash buffer II was repeated once more. 
Flow- through was discarded and the column was centrifuged again for 2 minutes at 
9000 RPM. The column was transferred to a new RNase free tube and 50 µl of RNase 
free dH2O was directly added on to the matrix. 
 
The concentration of extracted RNA was measured by nanodrop (Thermo scientific 
Nanodrop 3300) and was treated by DNase I (SIGMA- ALDRICH) to remove con-
taminating genomic DNA. For this purpose 1.3 µg of RNA isolate (1.63 µl of wild 
type RNA & 1.5 µl of Mutant type RNA), 1 µl of DNase buffer, 1 µl DNase I and 6.5 
µl of dH2O were added to a 10 µl reaction mixture followed by a 20 minute 
incubation period at room temperature. Later digestion reaction was stopped by using 
1 µl of stop buffer and placing the samples in a PCR machine (GeneAmp® PCR 
System 9700-Applied Biosystems) and incubated for 10 minutes at 70 °C. After 
incubation samples were immediately placed on ice to proceed with cDNA synthesis. 
 
2.2.6.9 cDNA Synthesis 
 
cDNA was prepared (Roche Diagnostics GmbH, Mannheim, Germany) by adding 2 
µl of random hexamers to the DNase digested RNA samples (11 µl). Lids were closed 
properly and after a gentle mix, samples were placed in thermal cycler (GeneAmp® 
PCR System 9700-Applied Biosystems) and denatured at 65 °C for 10 minutes. Dur-
ing this time the master-mix for cDNA synthesis was prepared using 4 µl of Reverse 
Transcription 5X Buffer, 0.5 µl RNAase inhibitor, 2 µl of dNTP mix, 1 µl DTT and 
1.1 µl of Reverse Transcriptase. Sample were placed on ice and to each sample 8.6 µl 
of master mix was added, and samples were again placed in the thermal cycler for 45 
minutes at 50 °C followed by 5 minute treatment at 85 °C. Samples were once again 
placed on ice to proceed with subsequent experiments. 
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2.2.6.10 RT-PCR 
 
RT-PCR was carried out using specific pSPL3 exonic primers. A 25 µl reaction mix-
ture was prepared as mentioned before (2.2.4.2) using 4 µl cDNA instead of genomic 
DNA. The cycling conditions for RT-PCR were followed by 95 °C for 3 minutes, 35 
cycles of 95 °C for 15 seconds, 55 °C for 15 seconds and 72 °C for 30 seconds, 1 cy-
cle at 72 °C for 7 minutes and a final stop at 4 °C forever. 
 
Once RT-PCR was over, cDNA samples underwent the routine protocol for sequenc-
ing with vector specific primers SD6 and SA2 that flank the insert (Table 2.19). 
 
2.2.7 RD Panel Next Generation Sequencing 
 
Next generation sequencing (NGS) is a new technique with great advantages that ena-
bles sequencing of a large number of currently known retinal dystrophy (RD) associ-
ated genes with added advantages as compared to the conventional Sanger sequencing 
(Glöckle et al., 2014). Three families A, E and H were not mapped to any potential 
candidate RP or RD gene and were selected for an RD diagnostic panel based screen-
ing. This panel targets 105 genes and the resulting data can be filtered and analyzed to 
identify the pathogenic variations. 
 
The diagnostic panel testing was performed on the HiSeq 2500 platform via next 
generation sequencing (CeGaT GmbH, Tuebingen, Germany). For this purpose 50 
ng/µl concentration of genomic DNA of the selected samples initially underwent 
quality control and fragmentation. Resulting sequence reads were aligned and mapped 
to the reference genome (Hg19) to identify the variations for each patient sequenced 
by this panel. Identified variants were further filtered against the public data bases like 
1000 genomes (http://www.1000genomes.org/), dbSNP 
(http://www.ncbi.nlm.nih.gov/SNP/) and ExAc (http://exac.broadinstitute.org/) to 
reduce the list of variants for further follow-up. Initial preference was given to 
variants identified within RP gene but later variants from other retinal dystrophies 
were also included in the analysis. Finally we selected the coding and splice site 
variations which were than screened in the available members of each family to figure 
out their segregation with the disease phenotype. 
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Figure 2.1 Over view of Nsp I GeneChip® Mapping Assay. The genomic DNA is 
digested and ligated with adaptors and undergo amplification. They are further 
fragmented and prepared for hybridization and scanning. 
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Direct sequencing with GSPc 
 
 
 
 
 
 
Figure 2.2 Schematic representation of DNA walking strategy used to identify 
deletion in LCA5 gene. Green box represents the location of GSPa, blue represents 
GSPb & purple identifies the binding position of the GSPc primers. Final PCR 
product is directly sequenced with GSPc primer. 
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Figure 2.3 Transformation was performed using NEB 10-beta Competent E.coli cells 
and incubated overnight. Colony PCR was performed on selected bacterial colonies to 
screen for clones of desired interest. Plasmid DNA was purified with Mini prep 
procedure and further sequenced to check for presence of the desired DNA. 
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Table 2.1 Markers flanking the genes/loci used to perform Homozygosity in seven 
families. 
 
Genes/Loci Markers Genetic Position Physical Position(bp) 
ABCA4 (RP19) D1S1588 p22.1 92,114,212 
 D1S406 p22.1 92,926,685 
 D1S1587 p22.1 98,429,420 
 D1S1170 p22.1 92,442,034 
RGR D10S523 q23.1 86,906,188 
 D10S1174 q23.1 85,523,551 
 D10S1432 q23.1 74,559,213 
 D10S1677 q23.1 80,107,026 
 D10S201 q23.1 80,928,992 
CERKL (RP26) D2S385 q31.2 179,525,378 
 D2S300 q31.2 178,523,628 
 D2S324 q31.2 179,556,226 
 D2S2978 q31.2 181,017,098 
 D2S273 q31.2 193,476,275 
CNGA1 D4S1627 p13 44,078,786 
 D4S3241 p13- p12 44,469,115 
 D4S2300 p13 48,857,202 
 D4S3255 q11- q12 52,699,598 
CNGB1 D16S3094 q21 59,524,047 
 D16S3057 q21 57,429,498 
 D16S3132 q21 60,096,390 
 D16S489 q12.2 55,259,315 
NR2E3 D15S1015 q23 67,739,179 
 D15S650 q23 70,156,998 
 D15S188 q24.1 73,970,633 
 D15S991 q24.1 74,500,582 
PDE6A D5S1483 q31.3- q32 144,479,593 
 D5S436 q32 145,103,918 
 D5S2490 q32 146,884,247 
 D5S812 q32 148,908,714 
 D5S1507 q33.2 155,149,938 
PDE6B D4S432 P16.3 3,977,836 
 D4S2285 P16.2 5,003,989 
 D4S2366 P16.1 6,384,678 
 
bp= base pair 
 
Linkage Analysis of Pakistani Families with Autosomal Recessive Retinitis Pigmentosa 46 
Chapter 2 Materials & Methods 
 
 
 
 
Genes/Loci Marker Genetic Position Physical Position 
RHO D3S3607 q21.3 127,172,891 
 D3S2316 q21.1- q21.2 123,771,256 
 D3S2322 q22.1 132,586,208 
 D3S1541 q22.1 131,620,284 
RLBP1 D15S811 q25.2 83,358,025 
 D15S652 q26.1 92,417,335 
 D15S655 q25.3 87,876,034 
 D15S984 q24.3 77,796,867 
SAG D2S2344 q37.1 233,344,517 
 D2S2973 q37.2 235,931,341 
 D2S1279 q37.1 233,850,680 
 D2S2176 q37.1 233,647,633 
RP29 D4S2290 q34.1 175,365,308 
 D4S2431 q34.1 174,720,572 
 D4S1501 q34.1 180,187,051 
PROM1 D4S2362 p15.32 15,357,866 
 D4S1511 p15.33- p15.32 15,017,900 
 D4S1525 p15.32 16,483,395 
 D4S2289 p15.32 19,590,752 
NRL D14S615 q12 28,416,647 
 D14S80 q12 27,624,420 
 D14S128 q31.3 86,280,605 
 D14S548 q31.3 21,920,668 
CRX D19S543 q13.32 45,800,480 
 D19S219 q13.32 45,893,577 
 D19S408 q13.32 43,947,259 
 D19S412 q13.32 46,910,944 
IMPG2 (RP56) D2S417 p11.2 86,887,914 
 D2S2216 p11.2 88,309,641 
 D2S2159 q11.1 95,949,775 
 D2S2209 q11.1 101,142,179 
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Genes/Loci Marker Genetic Position Physical Position 
CC2D2A D4S2311 p15.33 13,474,849 
 D4S1511 p15.33- p15.32 15,017,900 
 D4S2362 p15.32 15,357,866 
 D4S1525 p15.32 16,483,395 
TTC8 (RP51) D14S1063 q31.3 87,281,508 
 D14S1058 q31.3 88,548,119 
 D14S256 q31.3 89,111,459 
 D14S1066 q31.3 89,702,247 
CRB1 (RP12) D1S1189 q31.1 190,017,518 
 D1S2625 q31.1 192,168,625 
 D1S1660 q31.3- q32.1 198,511,279 
 D1S2840 q31.3 198,158,112 
LRAT D4S1548 q31.3 152,037,903 
 D4S3049 q31.3 154,674,450 
 D4S413 q31.3 158,253,155 
 D4S1629 q31.3 158,236,805 
MERTK D2S1891 q14.1 109,993,920 
 D2S410 q14.1 116,140,907 
 D2S1890 q12.3 108,319,170 
RPE65 D1S1180 p31.1 73,119,305 
 D1S1178 p31.1 71,346,870 
 D1S1665 p31.1 74,129,381 
 D1S3467 p31.1 64,305,910 
TULP1 (RP14) D6S1014 p21.33- p21.32 32,091,561 
 D6S2439 p21.33- p21.32 24,206,692 
 D6S1051 p21.33- p21.32 36,532,927 
 D6S1611 p21.33- p21.32 35,272,596 
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Genes/Loci Marker Genetic Position Physical Position 
USH2A D1S2827 q41 216,039,054 
 D1S2141 q41 215,095,283 
 D1S549 q41 219,543,613 
RPGRIP1 D14S1043 q11.2 21,275,513 
 D14S1070 q11.2 21,448,252 
 D14S283 q11.2 22,587,415 
RDH5 D12S1707 q13.2 54,934,045 
 D12S1990 q13.2 54,985,166 
 D12S1632 q13.2 56,315,338 
 D12S1644 q13.2 57,404,976 
SPATA7 D14S1063 q31.3 87,281,508 
 D14S68 q31.3 88,527,635 
 D14S140 q31.3 89,356,721 
 D14S1066 q31.3- q32.11 89,702,247 
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Table 2.2 Master mix for Nsp I enzymatic digestion, ligation and PCR master mix of 
genomic DNA 
 
Reagents for Digestion 1 Sample 
Accu GENE Water 11.55 µl 
NE Buffer 2 (10X) 2 µl 
BSA (100X; 10mg/ml) 0.2 µl 
Nsp I (10 u/µl) 1 µl 
Total 14.75 µl 
Reagents for ligation 1 Sample 
Adaptor NSP I (50 µM) 0.75 µl 
T4 DNA Ligase Buffer (10X) 2.5 µl 
T4 DNA Ligase Buffer (400 U/µl) 2 µl 
Total 5.25 µl 
Reagents for PCR 1 Reaction 
AccuGene Water 39.5 µl 
TITANIUM Taq PCR Buffer (10X) 10 µl 
GC- Melt (5M) 20 µl 
dNTP (2.5 mM each) 14 µl 
PCR Primer 002 (100 µM) 4.5 µl 
TITANIUM Taq DNA Polymerase 2 µl 
Total 90 µl 
 
 
Table 2.3 Master mix for Purification and Elution 
 
Quantity Reagent 
1 Clean up Plate (Clonetch) 
3 mL EDTA, diluted to 0.1M (working stock is 0.5 M, pH 8.0) 
5 mL RB Buffer 
75 mL AccuGene Water, molecular biology-grade 
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Table 2.4 Reagents, master mix & hybridization master mix for DNA fragmentation 
 
 
Reagent Fragmentation Reagent Concentration 
 2 U/µL 3 U/µL 
AccuGene Water 525 µL 530 µL 
Fragmentation Buffer 60 µL 60 µL 
Fragmentation Reagent 15 µL 10 µL 
 
Total (96 samples) 600 µL 600 µL 
Reagent Fragmentation Reagent Concentration 
TdT Buffer (5X) 14 µl  
GeneChip DNA Labeling Rea-   
gent (30 mM) 2 µL  
TdT enzyme (30 U/µL) 3.5 µL  
Total 19.5 µL  
Reagent Fragmentation Reagent Concentration 
MES (12X; 1.25 M) 12 µL  
Denhardt's Solution (50X) 13 µL  
EDTA (0.5 M) 3 µL  
HSDNA (10 mg/mL) 3 µL  
OCR, 0100 2 µL  
Human Cot-1 DNA (1 mg/mL) 3 µL  
Tween-20 (3%) 1 µL  
DMSO (100%) 13 µL  
TMACL (5 M) 140 µL  
Total 190 µL  
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Table 2.5 Staining buffer and SAPE & Anti- streptavidin antibody solution mix 
    
Components 1X Final Concentration  
H2O 800.04 µL   
SSPE (20X) 360 µL 6X  
Tween-20 (3%) 3.96 µL 0.01%  
Denhardt's (50X) 24 µL 1X  
Subtotal 1188 µL   
Subtotal/2 594 µL   
Components Volume Final Concentration  
Stain Buffer 594 µL 1X  
1 mg/mL Streptavidin Phycoerythrin 6.0 µL 10 µg/mL  
Total 600 µL   
Components Volume Final Concentration  
Stain Buffer 594 µL 1X  
0.5 mg/mL biotinylated antibody 6.0 µL 5 µg/mL  
Total 600 µL   
 
 
 
Table 2.6 Array holding buffer 
 
Components Volume 
  
MES Stock Buffer (12X) 8.3 mL 
5 M NaCl 18.5 mL 
Tween-20 (10%) 0.1 mL 
Water 73.1 mL 
Total 100 mL 
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Table 2.7 List of primers used in amplification and sequencing of ZNF513 gene 
 
Primer Sequence Tm Product Size 
Ex-1-F CTGAGAGGAAGGGCAGACAG 60.1 °C 243 bp 
Ex-1-R CCACTTCATCCCTCAGGAGT 59.1 °C  
Ex-2-F CGAGTACGGGAAGTGTGGTC 60.6 °C 300 bp 
Ex-2-R CACCTAACCTGCCTCCTGAA 60.2 °C  
Ex-3-F TGGAGCCTGATCCTACCCTA 59.6 °C 693 bp 
Ex-3-R CTAGGGTCAGCCACCCATGT 62.3 °C  
Ex-4-FA AGACACACCAGGGACCAAAG 60.0 °C 487 bp 
Ex-4-RA AGCAGAGGCATAAGGACAGC 59.6 °C  
Ex-4-FB TGCCTCTGCTCATCTGGATA 59.5 °C 500 bp 
Ex-4-FB GGGAGAAAAAGGTGGCTTCT 59.5 °C  
 
 
 
Table 2.8 List of primers used in amplification and sequencing of VSNL1 gene 
 
   Product 
Primer Sequence Tm Size 
EX1-F CATGGGGGATCTTTTGGAAT 60.9 °C 689 bp 
EX1-R TCTTCCAGTTTCTGGGCAAG 60.4 °C  
EX2-F ACCATGGGACTGCTCAGAAC 60.1 °C 448 bp 
EX2-R TTGCTTATTTTGGGAACAACA 58.2 °C  
EX3-F TCACCCACAGGAAACAATGA 59.9 °C 694 bp 
EX3-R GGTTCGTGGGAGATCCAGTA 59.9 °C  
EX4-P1-F TGCAGCACAAGGAGTGAAAC 60.0 °C 841 bp 
EX4-P1-R CAAGCTTCTGTGGTGTGTGG 60.3 °C  
EX4-P2-F TGCATCCTATCGATCTGGAAA 60.6 °C 568 bp 
EX4-P2-R CTTATGTTGGGGGACACCTG 60.6 °C  
EX4-P3-F TCCCAAATCTAAAGTAGGCAAAA 59.2 °C 568 bp 
EX4-P3-R TCAGGGCAGAATTTTGGTTC 60.1 °C  
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Table 2.9 List of primers used in amplification and sequencing of C2ORF71 gene 
 
Primer Sequence Tm Product Size 
Ex1-P1-F ATTGTGAAGGTGGGTGGAAG 59.8 °C 730 bp 
Ex1-P1-R GGCTGATCTCCTCAAAGCAC 60.0 °C  
Ex1-P2-F CTGCAACCCACTTGGAAAAT 60.0 °C 766 bp 
Ex1-P2-R GGCACAGGGACAAACTTGAT 60.0 °C  
Ex1-P3-F CAGAGCCAGGAGCAAATTCT 59.6 °C 576 bp 
Ex1-P3-R GAGGTTCCCCTCCATTTCAC 60.7 °C  
Ex1-P4-F AGAAGGCCACCAGCCTCTAC 60.8 °C 691 bp 
Ex1-P4-R GAGTCTGCTCTCAGCCAAGG 60.3 °C  
Ex1-P5-F AATTCTGGCCTGAAAATTGC 59.2 °C 844 bp 
Ex1-P5-R GAGCACTTCTCCATCCTTGG 59.8 °C  
Ex1-P6-F CACCAGCAGGCTTACACCTA 58.9 °C 595 bp 
Ex1-P6-R ACTTCCATTCTTCGGGCTCT 60.2 °C  
Ex1-P7-F AAGGCCACAATCTTCACCTG 60.1 °C 453 bp 
Ex1-P7-R GTGGTGTTGCTTGGACTGAC 59.2 °C  
Ex1-P8-F ATCTTTCCCCCTCTGCCTAA 60.0 °C 511 bp 
Ex1-P8-R CTGAGGTCCTGTTTTGTCCAG 59.7 °C  
Ex1-P9-F CCAAAGTGTCTGGGAACACA 59.6 °C 395 bp 
Ex1-P9-R CCATTCGCTCTGTTCCTCTC 60.0 °C  
Ex2-F TGTCTGACCTGCACTTGTCC 59.9 °C 330 bp 
Ex2-R GTTTGGTTTGCCCATCATCT 59.8 °C  
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Table 2.10 List of primers used in amplification and sequencing of FAM161A gene 
 
   Product 
Primer Sequence Tm Size 
EX1_F ATAGCAACCGGCTCCCTAGC 60.8 °C 381 bp 
EX1_R TTACCAGCCTGCCCTCAG 59.9 °C  
EX2_F AGCAGCATTTTGGATCAGTG 58.9 °C 395 bp 
EX2_R TGAAGTAACTTTGTTCTGTCCTTTT 57.7 °C  
EX3_P1F CCGATATCACACCACTGCAC 59.9 °C 384 bp 
EX2_P1R AGCTGCATGGAAGCCAGTAT 59.9 °C  
EX3_P2F GGGAAAAGCAGCTGAGAGAC 59.2 °C 627 bp 
EX2_P2R TGCATACACTCATCTGGCAAC 59.7 °C  
EX4_F TCAAAATTCAAATTATCCCATGTT 58.7 °C 356 bp 
EX4_R AATGCTATTTTCAATCTGCTCAT 57.1 °C  
EX5_F TCTGATTTGTCAGCTAAGCTAAATGT 59.9 °C 379 bp 
EX5_R TGATGAAGCCAACACAAACAA 60.1 °C  
EX6_F GCGCCTGGCCTAATCTATAC 58.8 °C 300 bp 
EX6_R TTGTGCTTTTCTGCAGGTAATA 57.7 °C  
EX7_F CCTTTAAACCAACTCATTTTTCC 58.2 °C 299 bp 
EX7_R ATATCAGAAGCGTCCCCACA 60.5 °C  
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Table 2.11 List of Primers used in amplification and sequencing of C8ORF37 gene 
 
   Product 
Primers Sequence Tm Size 
Ex1-F CAGGTCCCCTCGTTACTCCT 60.5 °C 358 bp 
Ex1-R GGTCTGAACCCTGATGCAAG 60.7 °C  
Ex2-F GCTTTCTCTGCTCATAAACCTCA 60.0 °C 346 bp 
Ex2-R GAAATGCACAGGGAAACACA 59.5 °C  
Ex3-F TGCACATTCCTTAGGGAGTTCT 59.9 °C 450 bp 
Ex3-R ACACAAAGGGGGTCACAGAC 59.9 °C  
Ex4-F GAAATGGTTGGCTTGCTAGG 60.1 °C 459 bp 
Ex4-R CTGGAGTGATCCAGGCATTT 60.1 °C  
Ex5-F AAATCACCATGTTTTCATTGG 57.3 °C 325 bp 
Ex5-R GTCCATCGTTGACTGAAGCA 59.8 °C  
Ex6-P1-F AAGCACTGAACAAAGCCACT 57.6 °C 681 bp 
Ex6-P1-R GGTTTCTGCCATGTCCAAAT 59.8 °C  
Ex6-P2-F ATTTGGACATGGCAGAAACC 59.8 °C 769 bp 
Ex6-P2-R TGTGTCATGGCTAGGAAAAGG 60.1 °C  
Ex6-P3-F TTATTCCAGCCACCCTACTGA 59.6 °C 606 bp 
Ex6-P3-R TGTGGATCTTGTTGCTCTGC 60.0 °C  
Ex6-P4-F TGAAGTCGACTGCTGGAAAA 59.6 °C 595 bp 
Ex6-P4-R GCTTATAAATTGCCAATAAACATGG 60.0 °C  
Ex6-P5-F TGCCTCTACTTTGAAGGGACA 59.9 °C 836 bp 
Ex6-P5-R GCATACTTCTCCTCCCCAGT 58.2 °C  
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Table 2.12 List of primers used for amplification and sequencing of RP1 gene 
 
Primers Sequence Tm Product Size 
EX1-F CTCAATCCCTTGCTGGACAT 60.1 °C 485 bp 
EX1-R ACAAGCAGCTGTCTTCTTCTTT 57.6 °C  
EX2-F TCGCTATGGTGCTGTGATTC 59.8 °C 814 bp 
EX2-R ATCGGAGCACACACACTCAC 59.7 °C  
EX3-F TGCTCATCTCAGGATAATGACTC 58.4 °C 250 bp 
EX3-R TCAGGGCTAAAAATATGGGCTA 60.0 °C  
Ex4-P1-F TTTTGATGTGGGCACCTTTT 60.3 °C 452 bp 
Ex4-P1-R TTGATTACTGCTTCGCTCCA 59.6 °C  
Ex4-P2-F AGACCAAGCAAAGCATCGTT 59.9 °C 845 bp 
Ex4-P2-R GGGGACTATCTGAATCTTGCAC 60.0 °C  
Ex4-P3-F TGTGAGGAAGACCTCCAGAAA 59.8 °C 694 bp 
Ex4-P3-R GGGGATCATTCCCTGAAAAA 61.0 °C  
Ex4-P4-F GCCGGTTTGACAGGAGATAA 60.1 °C 658 bp 
Ex4-P4-R CACTGAGTCCAAAGTGGCTTG 60.9 °C  
Ex4-P5-F GCTCTCCATGTGAGATGTGC 59.4 °C 836 bp 
Ex4-P5-R TGTTGCCAGCCTCTTACTGA 59.6 °C  
Ex4-P6-F TGGTGAAAACTATGGAAACTGG 59.0 °C 691 bp 
Ex4-P6-R GGGGCCAAATTACCAAAATG 61.2 °C  
Ex4-P7-F AAGGCAAATGGCTTCTGAAA 59.8 °C 829 bp 
Ex4-P7-R CCTTCTTCCTCTAACCCCAAG 59.2 °C  
Ex4-P8-F TGTGTTCAGGGAAGAGAACAA 58.3 °C 778 bp 
Ex4-P8-R CCTGAGTCTGTAATTGTTGGAAAA 59.6 °C  
Ex4-P9-F GCTTACCCTTGGATAACCAGTTT 59.8 °C 496 bp 
Ex4-P9-R CTCCTGGGAAATACACCACAA 59.8 °C  
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Table 2.13 List of primers designed for amplification and sequencing of CLN3 gene 
 
   Product 
Primer Sequence Tm Size 
    
Ex1_F GACAAACGGCCTCTGCAT 59.8 °C 483 bp 
Ex1_R TGACCCCCACCTACTCTCAG 60.1 °C  
Ex2_F GGCACAGGTAAGGGAAGGTT 60.4 °C 244 bp 
Ex2_R GTCCCACCCCCTCATCTT 59.7 °C  
Ex3_F CAGCTCCTGCCTCTCCTTG 61.2 °C 240 bp 
Ex3_R CTCTCAGCATCTCAGCCATC 58.6 °C  
Ex4_F GATGGCTGAGATGCTGAGAG 58.6 °C 211 bp 
Ex4_R CCCACAAATGCTCTGATGTG 60.1 °C  
Ex5_F CAAGGTGTGGTGTGACCATC 59.8 °C 179 bp 
Ex5_R TTCAGGAGGACCTAGGCTGA 59.8 °C  
Ex6_F CATGGTCAGCCTAGGTCCTC 59.7 °C 248 bp 
Ex6_R CATGGCCAAGTTTTCTCTCC 59.7 °C  
Ex7_F CCAGCCAGTAGGGTTTTCTG 59.7 °C 221 bp 
Ex7_R AGAGAGGAAAAGGCCAAACC 59.7 °C  
Ex8_F TTTGCCGAGTCTTCAGTGTG 60.0 °C 184 bp 
Ex8_R TGGAAAAGGCAGAAGATATAAGC 59.0 °C  
Ex9_F GATGATGGCTGGGGTATGTC 60.2 °C 228 bp 
Ex9_R TACCAGACAGGGGAGATGGA 60.5 °C  
Ex10_F GGGTGCTAGGAGGGGTGT 59.9 °C 238 bp 
Ex10_R CTCCTCCAGGGACCATCC 60.4 °C  
Ex11_F GGATGGTCCCTGGAGGAG 60.4 °C 234 bp 
Ex11_R CCACTGATAGTGGGAAGCAG 58.3 °C  
Ex12_F GAGGCCACCTCTCCTTCC 59.7 °C 284 bp 
Ex12_R GTGAGGCTTCAGTCCCAGAC 59.8 °C  
Ex13_F GGCAGGGATGTCTGGGACT 62.5 °C 272 bp 
Ex13_R CTGGGAGCACAGTTCATGG 60.4 °C  
Ex14_F AGTGGAATCCCACGGTGATA 60.2 °C 459 bp 
 TTATGCTAA-   
Ex14_R TAAATCATTTCCCTGA 58.3 °C  
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Table 2.14 List of primers designed for amplification and sequencing of LCA5 gene 
 
 
    Product   
 Primer Primer Sequence TM size   
 Ex1-F CCCATCCTTGTGTTCAAACC 60.2 °C 698 bp   
 Ex1-R CGGCTTTCCACTCTAACCAC 59.7 °C    
 Ex-2-F GATGGGTCCTAGGAATTGGTC 59.6 °C 297 bp   
 Ex-2-R TTCTGTTCTCGCATTACTGAGG 59.5 °C    
 Ex-3-F TCAGGATCTGAAGACTGTGAAAA 59.0 °C 367 bp   
 Ex-3-R TCATGCACACACATTTTCCTT 59.0 °C    
 Ex-4-F ACGGACCCACTTGTGTTAGG 59.9 °C 669 bp   
 Ex-4-R ATGCCCAATGAGAAACATCC 59.9 °C    
 Ex-5-F CACTGCCATGTGTTATGTTTCA 59.5 °C 365 bp   
 Ex-5-R CCAACAAACCTTTTCTAAGTGC 58.0 °C    
 Ex-6-F AATTGTATTGCGTTTGTTTTCAG 58.3 °C 296 bp   
 Ex-6-R TGGAGAAAACAGAAAAGGATTT 57.0 °C    
 Ex-7-F CATGCCAGCTGAATTCCATA 59.6 °C 352 bp   
 Ex-7-R CCCTTCAAAAAGGCTAGTCG 59.0 °C    
 Ex-8-F CCCCCTTTTCTATAATTTGTGA 57.2 °C 238 bp   
 Ex-8-R TTCTTTCTCAAGGGATGCTGA 59.9 °C    
 Ex-9-FA TGGTGGTTTTATGAAAGTTGATAGTT 59.3 °C 379 bp   
 Ex-9-RA TGTTTTGGGGCTTCTCTCTG 60.4 °C    
 Ex-9-FB TCGCATTTGGTAGCTACGTG 59.9 °C 596 bp   
 Ex-9-RB TGATCTACTTCTTTTTAACTGCATTG 58.2 °C    
 In4-5-P1-F GGATCATAGTCATTTTGGGAAA 57.9 °C 600 bp   
 In4-5-P1-R TGGGCATGGCATATTATATAGAG 58.1 °C    
 In4-5-P2-F TGCACTTGCTGGTTTTATGA 57.9 °C 585 bp   
 In4-5-P2-R TTGACACCAAAGCACAATCC 59.5 °C    
 In4-5-P3-F TTTCAGTGGAGACGGGATTC 60.0 °C 727 bp   
 In4-5-P3-R AAAGCTGCTTGCCACAATTT 59.9 °C    
 In4-5-P4-F TGGGAAACTGTCTTCTAAGCAT 58.0 °C 599 bp   
 In4-5-P4-R TTCCAAGCCACTAGAGCAAAA 60.0 °C    
 In4-5-P5-F TGTTGGCTTTTGTTTTGAGG 58.8 °C 798 bp   
 In4-5-P5-R ATTATTTCCAGGGGCCTTTC 59.3 °C    
 In4-5-P6-F TGGAGAAGTATGGACTGGTTGA 59.6 °C 559 bp   
 LCA5-In4-      
 5-P6-R TGGGTTAACTTCTTCCCTTCTG 59.6 °C    
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 LCA5-In4-          
 5-P7-F CCTTTTTCTACTCTCCTTGCTCA 59.2 °C  832 bp  
 LCA5-In4-          
 5-P7-R CCACTCAGAAGCCCTCACTT 59.5 °C     
 LCA5-In4-          
 5-P8-F TGGATGGGCAATAAACATGA 59.7 °C  692 bp  
 LCA5-In4-          
 5-P8-R CAGGAGAAAGAAAAGCCAGTG 59.1 °C     
 LCA5-In4-          
 5-P9-F TAAACCTGATGGGCCATGTT 60.2 °C  593 bp  
 LCA5-In4-          
 5-P9-R CATGGCAGTGTCAAAATGATG 60.2 °C     
 LCA5-In4-          
 5-P10-F TCAAAGGTCAGGAGTTCTTGATT 59.3 °C  600 bp  
 LCA5-In4-          
 5-P10-R ACTACCAAAGCTGCGGAGAG 59.6 °C     
 
 
 
Table 2.15 List of primers designed  for amplification  and sequencing of LCA5 
 
Deletion and SH3BGRL2 
 
LCA5_A3del_F GCATCCTGTCAGATCAGCAA 60.2 °C 200 bp 
LCA5_A3del_R AGAGCCTTTTTGCCCCTAAG 59.9 °C  
SH3BGRL2-Ex1-F TCGTAGCTGGGTTCAGCTCT 60.2 °C 499 bp 
SH3BGRL2-Ex1-R ACCAGTCTGAAGGTCCCAAA 59.5 °C  
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Table 2.16 List of primers designed for amplification and sequencing of NMNAT1 
 
gene 
 
   Product 
Primers Sequence Tm Size 
Ex1-F CCCTGGAACCAATGAGAGTG 60.5 °C 250 bp 
Ex1-R GGTCAATCAAAGCTCCTTGC 59.8 °C  
Ex2-F AGTTTGAGGGTGCAGTCAGC 60.5 °C 339 bp 
Ex2-R ACCCGGCTGGTTCTCTAGTC 60.3 °C  
Ex3-F TTGATCGTAATATTTCCTGTGCAT 59.8 °C 390 bp 
Ex3-R GGAATGGCTTACAACACACG 59.0 °C  
Ex4-F GGAGCATGTGAGAAAGAGAAA 57.1 °C 250 bp 
Ex4-R GGGTTTGCTCAGCTACAGAA 58.1 °C  
Ex5-F CCCTCATCCTTGAAAAGCAC 59.7 °C 577 bp 
Ex5-R GATCCCCAAATGGGAAGTCT 60.1 °C  
 
 
 
Table 2.17: Gene specific primers for DNA walking for LCA5 gene and splicing assay 
 
and in-vitro mutagenesis for C8ORF37 gene 
 
Primers Sequence Tm °C 
LCA5-GSPa TGCTGTTCATTATTAGGGTGCTCCA 65.8 
LCA5-GSPb AATCAAGAACTCCTGACCTTTGA 59.3 
LCA5-GSPc GACTAGGGAAAATATGTGCAAATCCCC 66.41 
C8ORF37 splice-F ATATAAGCGGCCGCGCTTTGCCTG- 60.2 
 CAGAAGGTAG  
C8ORF37 splice-R ATAAAGGATCCAAATGCCAATGGAATGT 60.3 
 GCT  
C8ORF37 Mutg-F GGCCTTTTATTGTTTTCTTTTTTAACAGAA 78° 
 ATTAAAATCTAAATCTTCAGGTAACAC  
C8ORF37 Mutg-R GTGTTACCTGAAGATTTAGAT- 79 
 TTAATTTCTGTTAAAAAAGCAAAACAA-  
 TAAAAGGCC  
SD6 TCTGAGCCTGGACAACC 58.0 
SA2 ATC TCAGTGGTATTTGTGAGC 58.0 
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RESULTS 
 
For this study, eight (A-G) families with autosomal recessive RP were collected from 
different regions of the Pakistan. Majority of the families (A, C-F, H) were recruited 
from different cities of the Punjab province but one family was collected from each 
province i.e Khyber PakhtunKhwa (G) and Sindh (B). These families were collected 
by visiting their places of residence by following the protocols approved by the 
institutional ethics review committee. Current study focused on families with 
recessive RP, which were later subjected to genetic analysis to identify the underlying 
causal variants. 
 
3.1 Clinical presentation of the studied families 
 
3.1.1 Family A 
 
 
Family A, a five generation family (Figure 3.1A), depicts consanguinity in the third 
generation and contains seven affected members (III:1, IV:2, IV:3, IV:5, V:1, V:3 & 
V:5). All affected individuals experience night blindness since early childhood, but 
the loss of day vision started after the age of 10 years. The day vision loss was 
progressive until they become legally blind at the age of 50 years. Clinical evaluation 
of two patients (IV:2; 70yrs and V:1; 38yrs) in the year 2005 showed complete loss of 
night vision and severe loss of day vision. Fundus examinations of patients IV:2 and 
V:1 revealed typical signs of RP including severe attenuation of blood vessels, 
pigmentary degeneration, waxy pallor of the optic disc and sluggish pupillary 
response (Figure 3.1B). The pigmentary changes were more severe in a 70 year old 
patient as compared to the younger 38 year patient which is indicative of progressive 
nature of vision loss in this family. Diagnosis of retinitis pigmentosa in the affected 
members of family A was based on nyctalopia before the age of 10, progressive loss 
of peripheral vision and reduced visual acuity. Clinical history and medical 
examinations ruled out the possibility of any other ocular or non-ocular disorders. 
 
3.1.2 Family B 
 
Family B is a consanguineous family (Figure 3.2) with two affected members (V:3, 
V:4) and was ascertained from the Sind province of Pakistan. Five individuals from 
this family i.e IV:1, IV:2, V:2, V:3, V:4 participated in the study. Both patients 
experience night blindness since the age of 2 years and initially have normal day 
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vision. At the time of visit they complained complete loss of night vision and reduced 
day vision. The vision of both affected individuals is now limited to light perception 
and hand motion with absence of peripheral vision. Detailed eye examinations 
conducted by a doctor at the local eye hospital revealed Retinitis Pigmentosa in all the 
affected individuals of the family. Fundus analysis of an affected individual V:3 
showed atypical hallmarks of RP including atrophy of the peripheral retina, disk 
pallor with non-typical waxiness, lack of bony spicules and mild attenuation of the 
blood vessels. Ocular examination of the parents of the affected individuals showed 
clear fundus and no sign of RP or any other ocular disorder (Figure 3.2B). 
 
3.1.3 Family C 
 
Family C is a large consanguineous family with two loops and was enrolled from the 
Dera Ghazi Khan village in Punjab province in Pakistan. The pedigree represents five 
generations with eight affected individuals from which III:1, III:2, V:5 , V:6, V:7, V:8 
were enrolled for the study (Figure 3.3A). The clinical evaluation of the affected 
individuals V:6, V:7, V:8 were conducted when patients reported blurry and 
progressive loss of vision accompanied with night blindness around ages 5-9 years. 
All patients were diagnosed with retinitis pigmentosa after a thorough examination by 
the ophthalmologist. Funduscopic examinations of the right eye of patient V:8 
revealed hyper pigmented spots at the macula, waxy disk pallor, attenuated blood 
vessels, chorioretinal atrophy (Figure 3.3B). It is to be noted that an affected member 
of this family belonging to the second loop, was reported with postaxial polydactyly 
at birth. However such characteristics were not demonstrated in the patients included 
in this study. 
 
3.1.4 Family D 
 
Family D is a large consanguineous family enrolled from the rural areas of Punjab 
province of Pakistan. The family consists of seven generations with ten affected 
individuals confirming the autosomal recessive mode. In total four affected V:1, VI:3, 
VI:4, VI:5 and five unaffected individuals III:5, III:6, IV:1, V:1, VI:1, VI:2 
participated in the study (Figure 3.4A). The diagnosis of RP was based on the early 
childhood symptoms of night blindness. All affected members initially complained of 
nyctalopia followed by gradual loss of peripheral vison. Recent eye examinations of 
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VI:3 showed severely limited visual acuity to light perception. Funduscopic 
evaluations also revealed bony spicules, pigmentary changes, attenuated vessels and 
waxy pallor of the optic disk (Figure 3.4B). 
 
3.1.5 Family E 
 
This is a large family with multiple consanguineous marriages and was also enrolled 
from the Punjab province of Pakistan. For this study five individuals, three normal 
(III:1, III:2, IV:1) and two affected (IV:3, IV:4) were enrolled for the genetic analysis. 
(Figure 3.5A). Since early childhood these affected individuals have problems with 
night vision and also have reduced day vision. Although these five patients have non-
progressive night blindness but clinical evaluations by the local ophthalmologist 
concluded the diagnosis of RP. Fundus photograph of the proband IV:3 revealed pale 
optic disk and signs of myopia (Figure 3.5B). 
 
3.1.6 Family F 
 
Family F is also enrolled from Dera Ghazi Khan city in the Punjab province of 
Pakistan. It consists of six affected individuals and two sib ships. Four individuals 
IV:2, IV:3, IV:4, IV:5 were enrolled for this study (Figure 3.6A). A detailed medical 
history was established in all patients which revealed the decreased visual acuity since 
early childhood along with bilateral nystagmus. Additional investigations indicate 
normal peripheral vision but either reduced or the complete loss of central vision in 
the affected individuals. The older patients were completely blind and could not even 
respond to light stimulation. The fundoscopic image of an affected individual is 
shown in (Figure 3.6B), which clearly depict retinal and macular abnormalities. 
 
3.1.7 Family G 
 
A consanguineous four generation family from Abbottabad, Khyber PakhtunKhwa 
province has four affected individuals (IV:3, IV:4, IV:7, IV:8) in two sib ships. 
However, seven individuals (III:2, IV:2, IV:3, IV:4, IV:6, IV:7, IV:8) were enrolled in 
this study (Figure 3.7A). Based on the clinical symptoms presented by the four 
affected individuals, the family was diagnosed as RP by the local ophthalmologist. 
The affected individuals have reduced day vision since early childhood. Fundus 
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imaging from the right eye of the affected patient IV:3 showed attenuation of arteries, 
waxy pale disc appearance and pigmentary changes in the macula (Figure 3.7B). 
 
3.1.8 Family H 
 
Family H consist of three members (V:5, V:6, V:7) with vision loss (Figure 3.8). 
Peripheral blood samples were collected from the three patients (V:5, V:6, V:7) and 
three un-affected (IV:1, IV:2, V:3) individuals. All patients complaint of difficulty in 
night vision from early childhood with gradual reduction in visual acuity, photophobia 
and partial loss of peripheral vision. All patients had normal day vision. Due to lack of 
proper ophthalmic facilities in the village, fundoscopy could not be performed but 
ophthalmologist evaluations conclude the diagnosis of RP in the patients of this 
family. 
 
3.2 Homozygosity Mapping and Linkage Analysis of Families 
 
 
Initially Homozygosity mapping was performed for the eight families to test the 
involvement of loci/genes which are known to be responsible for autosomal recessive 
RP in the Pakistani population. For this purpose, 4-5 polymorphic markers (Table 2.1) 
flanking the selected RP or related RD genes were genotyped in these families to find 
the homozygosity across the tested genes/loci. Families negative for linkage or lack a 
homozygous region around a known RP or RD gene were subjected to the whole 
genome scan with 250K Nsp array (Affymetrix, USA) or Infinium® 
HumanCoreExome BeadChip (Illumina, USA). 
 
3.2.1 Homozygosity Mapping by STS Markers 
 
Analysis of the genotype data obtained for STS markers mentioned in table 2.1 
revealed the exclusion of tested genes/loci in our families except family B. Two 
affected members of the family B were homozygous for the markers on chromosome 
16, which forced us to genotype additional chromosome 16 markers in this family. To 
test the possibility of involvement of this genomic region, additional markers were 
genotyped and the data was used to construct the haplotype which revealed the 
presence of a homozygous region of 24.5 Mb. The identified homozygous region was 
delimited by markers D16S3145 (54.05 cM) and D16S770 (64.61 cM) and defines a 
region of 10.56cM (Figure 3.9), which corresponds to 24.5 Mb (GRCh37/hg19). 
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Linkage analysis using easyLinkagePlus V5.02 software yielded a maximum 
multipoint LOD score of 2.2769 at several markers (D16S409, D16S540, D16S261, 
and D16S517). Although the obtained multipoint LOD score is less than required 
significant score (i.e 3.0) but is very close to the expected LOD score for family B 
pedigree structure. Similarly two point linkage analysis yielded a LOD score of 
0.8234 for several markers (D16S409, D16S540, D16S261, D16S517 and D16S3136) 
(Table 3.1) mapped within the homozygous region identified in family B. Taken 
together these results suggest that the disease causing gene is located within the 24.5 
Mb interval on chromosome 16p12.1-q12.1. 
 
3.2.2 Homozygosity Mapping by SNP Markers 
 
In case of the remaining seven families, for which linkage could not be determined for 
the tested genes/loci through the microsatellite markers, SNP genotyping was 
performed on selected members of each family (Table 3.2). For family D, all available 
individuals underwent SNP genome wide scan with 500K array but all other families 
were processed with 250K Nsp array. The resulting genotyped data was evaluated by 
HomozygosityMapper (http://www.homozygositymapper.org/) to find homozygous 
regions shared by the affected individuals of each family. These results revealed the 
mapping of multiple homozygous regions in each family except family D, which was 
mapped to a single region on chromosome 2 (Table 3.3). Three families (A, D and G) 
showed the presence of two homozygous genomic regions, but all other families have 
3 or more homozygous regions (Figures 3.10-3.16). 
 
Homozygous regions identified in seven families were further analyzed with 
GeneDistiller (Seelow et al., 2008) to identify the known RP or RD genes which map 
within the identified homozygous regions of each family. The data was further 
compared with Retinal Information Network (RetNet; 
https://sph.uth.edu/retnet/disease.htm) to identify the plausible candidate for further 
follow up with Sanger sequencing. These analyses and comparisons revealed the 
identification of probable RP or RD candidates for all seven families (Table 3.3). 
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3.3 Screening of Candidate Genes 
 
After the identification of possible RP or RD candidate genes for each family, 
respective genes were sequenced in one affected member of the family to identify the 
underlying pathogenic variant. Details of each family are described below; 
 
3.3.1 Family A: 
 
Though GeneDistiller identified over 100 genes within the two homozygous regions 
identified on chromosome 2 (Table 3.3), but four genes were selected for Sanger 
sequencing. These genes include ZNF513, C2ORF71, FAM161A and VSNL1 which 
are already known to either cause autosomal recessive RP or retinal dystrophy. 
Sequencing of the coding and splice site regions of these four genes in individual IV:2 
did not reveal any pathogenic variation. Therefore the involvement of these four genes 
in causing autosomal recessive RP at this locus was not supported in this family. 
 
 
3.3.2 Family C: 
 
GeneDistiller identified 136 genes residing on various homozygous regions in Family 
C. DNA sample from individual V:8 was used to sequence RP1 and C8ORF37 genes. 
Sequence analysis did not reveal any pathogenic variation in RP1 gene but Sanger 
sequencing of the C8ORF37 gene showed a homozygous splice site variation. The 
variation c.244-2A>C affects the splice acceptor site of exon 3 and is predicted to 
result in protein truncation (p.G82VfsX44). The variation segregates with RP in the 
additional available members of the family C (Figure 3.17). 
 
3.3.3 Family D: 
 
In family D, Sanger sequencing of the FAM161A in individual VI:3 revealed a single 
nucleotide deletion mutation (c.786delT). The deletion results in the conversion of 
ATC codon (Isoleucine) to ACT (Threonine) codon at the site of breakpoint leading 
to a frameshift followed by 37 amino acids before a premature stop codon 
(p.I262Mfsx38). The mutation was confirmed in other family members and was found 
to be segregating with the arRP phenotype in the D family (Figure 3.18). The variant 
c.786delT is predicted as disease causing by mutation taster and is absent in 1000 
genome and ExAC data. The deletion lies in exon 3, which contains most of the 
currently known FAM161A mutations (Figure 3.19). 
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3.3.4 Family F: 
 
In this family RDH5 and LCA5 genes were selected for sequencing in the affected 
individual IV:3. All exons and flanking intronic regions were sequenced for both 
genes; however no pathogenic variation was identified in RDH5 gene. Interestingly, 
 
LCA5 gene could not be completely sequenced in this individual and failure of several 
attempts to amplify first four exons led us to systematically evaluate the presence of a 
large genomic deletion. 
 
3.3.5 Family G: 
 
In family G, GeneDistiller identified over 200 eye/vision associated genes, but none 
of these was directly associated with RP. Further analysis of the region revealed the 
presence of NMNAT1 gene, which is known to cause leber congenital amaurosis 
(LCA) (Chiang et al. 2012; Koenekoop et al. 2012; Falk et al. 2012). As a result DNA 
sample from individual IV:3 was used to sequence the NMNAT1 gene which result in 
the identification of a previously reported missense mutation c.25G>A (p.Val9Met) in 
exon 2 (Falk et al. 2012). The mutation segregated with the disease in this family 
(Figure 3.20). 
 
3.4 RD Panel Sequencing: 
 
In order to identify the underlying pathogenic variant, family A and two families with 
multiple homozygous regions (i.e family E and H) were subjected to panel based next 
generation sequencing. These analyses result in the identification of a causal mutation 
in family E but pathogenic variation could not be identified for two other families. 
 
3.4.1 Family A 
 
DNA sample of individual V:3 was subjected to RD panel sequencing and analysis, 
which did not revealed the presence of any homozygous pathogenic variant in the 
tested 105 genes. But additional analysis showed two heterozygous variants in USH2A 
gene in this affected individual. The variants, c.5653 A>G (p.R1885G) and c.14662 
A>T (p.T4888S) were identified in exon 28 and 67 respectively (Figure 3.21). Further 
testing of both the variants using two primer sets (Exon 28: forward 
gctgcagaggacaaaaatga; reverse ggaaataagatgcagcaagatt), (Exon 67: forward 
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tgaaaacaaaatgtctcctcaca; reverse agtggcttctccgagtttca) in the additional members of 
family A ruled out the segregation of both variants with the disease phenotype. 
 
3.4.2 Family E 
 
In family E, DNA sample of proband IV:3 was subjected to RD panel analysis. 
Results revealed a known homozygous missense mutation c.1600G>A (p.G534R) in 
exon 14 of the TRPM1 gene leading to altered gene function (Figure 3.21). By using a 
primer pair (forward: CGTGTGATGAAGTCCACACTG; reverse 
GTACTCGCGAACCACAGA) all available members of the family E were 
sequenced for exon 14, which revealed the segregation of c.1600G>A variant with the 
disease phenotype in the family (Figure 3.22). 
 
3.4.3 Family H 
 
RD panel NGS of individual V:5 in family H described a known missense mutation 
c.1208G>A, (p.Arg403Gln) in exon 11 of the CNGB3 gene. This variation is already 
reported in heterozygous state in patients with progressive cone rod dystrophy and 
achromatopsia along with a second variant in CNGB3 gene. A primer pair (forward 
CTATATTCTCCCAAGAATAGTGGTCT; reverse 
TCACATCCTCCTTCAACTCATT) was designed to sequence three additional 
individuals of this family, which clearly showed that variant is present in 
heterozygous state in an affected individual (V-6). Importantly, the third affected 
individual (V-7) was homozygous for the wild type allele (i.e G/G) and negates the 
pathogenicity of p.Arg403Gln variant (Figure 3.23). The re-evaluation of individual 
V:7 revealed the clinical presentation similar to his siblings with the vision problems, 
which also supports our earlier conclusion about the identified variant. 
 
3.5 Additional Analysis of Family A: 
 
As Sanger and RD panel sequencing failed to identify the disease causing variant in 
family A additional members of this family were genotyped for microsatellite markers 
on chromosome 2 to establish the disease segregating haplotype. Genotyping of 
additional microsatellite markers within the identified homozygous intervals on 
chromosome 2 (Table 3.3) revealed that all affected members were found 
homozygous while the unaffected individuals showed heterozygous pattern. 
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Haplotype analysis indicated the mapping of a 1.7 Mb region which was flanked by 
rs1429410 and rs1356314 markers (Figure 3.24). The 1.7Mb region was shared by the 
five affected individuals (IV:2, IV:3, V:1, V:3 & V5) and delineated by D2S312 and 
D2S175 markers and overlaps with the homozygous region identified by genome 
wide scan conducted only on affected individuals. 
 
LOD score calculations were carried out using easyLINKAGE plus v5.02 software. A 
maximum multipoint LOD score of 1.93 was achieved at D2S2346, D2S272, 
D2S1360 and D2S320 markers. Two-point linkage analysis also yielded a maximum 
LOD score of 1.8062 for D2S2295, D2S2346, D2S272, D2S1360, D2S320 markers 
(Table 3.4). 
 
3.6 Exon Trapping and Functional Analysis in Family C 
 
In order characterize the splice site variation c.244-2A>C identified in family C, the 
sequence of exon 2 to 4 along with required splice sites was amplified from an 
affected individual and cloned into pSPL3 vector. By using site directed mutagenesis 
a wild type allele was created, which lacks c.244-2A>C variation. Both mutant (with 
splice site variation; c.244-2A>C) and wild type alleles were transfected in HEK293 
cells and total RNA was extracted for subsequent use for reverse-transcription PCR 
and cDNA synthesis. Sanger sequencing revealed that the variation c.244 -2A>C in 
mutant allele affects the acceptor splice site of exon 3 and this is followed by the 
activation of a cryptic splice site within exon 3 (Figure 3.25). In the mutant allele use 
of cryptic splice site results in the deletion of a portion of exon 3, while wild type 
allele undergo normal splicing as expected. The deletion of 22 bps of exon 3 in the 
mutant allele is expected to result in a frameshift and premature termination resulting 
in the nonfunctional product of C8ORF37 gene. 
 
3.7 DNA Walking and Deletion Breakpoint Identification in Family F 
 
In order to determine the extent of the deletion, a genome walking strategy was 
implemented using APAgene™ GOLD Genome Walking Kit (BIO S&T, Quebec, 
Canada) according to the manufacturer's instructions. Evaluation of results revealed a 
large deletion of 110540 bps (g.[152634_42094]) encompassing 42 kb of the coding 
and non-coding regions of the LCA5 gene and 68 kb of the 5' upstream sequences. 
Sanger sequencing also showed the insertion of a single nucleotide 'A' at the 17875 
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bps position of the 19 kb stretch of 4-5 intronic region. This deletion was found to be 
32 kb distant from the neighboring upstream gene being SH3BGRL2 which is known 
to be expressed in the fovea (Mohamed et al., 2002) (Figure 3.26). This large deletion 
in LCA5 gene is predicted to interrupt the normal transcriptional activity due to the 
loss of promoter and regulatory regions. PCR based analysis also showed that 
 
LCA5 deletion exists in homozygous and heterozygous states in affected and normal 
individuals, respectively (Figure 3.27). So the loss of function of LCA5 gene due to 
the large deletion is responsible for disease phenotype in the affected individuals of 
family F. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Linkage Analysis of Pakistani Families with Autosomal Recessive Retinitis Pigmentosa 71 
Chapter 3 Results 
 
 
A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 (A) Pedigree of family A. Genotyped individuals are indicated with 
 
(*). B) Left and right eye fundus images of individual IV:2 and V:1 respectively 
showing bony spicule deposits at the retinal periphery, pigmentary degeneration 
and severely attenuated blood vessels. 
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Figure 3.2 (A) Pedigree of family B. Genotyped individuals are indicated with 
 
(*). B) Fundus photograph of the left and right eyes of individual V:3 shows 
depigmentation of the peripheral retina, disk pallor with non-typical waxiness, 
attenuated vessels and lack of bony spicules. 
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Figure 3.3 (A) Pedigree of family C. Genotyped individuals are represented 
with (*). B) Color and black and white fundus photographs of the right eye of 
V:13 individual showing hyper pigmentation at the macula, waxy pallor of the 
optic disk, narrowing of the vessels and chorioretinal atrophy. 
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Figure 3.4 (A) Family D pedigree with autosomal recessive RP. Marked (*) 
individuals were genotyped. (B) Fundus photograph of the left eye of individual 
VI:4 depicting typical features of RP such as bony spicules, pigmentary changes, 
attenuated vessels and waxy pallor of the optic disk. 
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Figure 3.5 (A) Pedigree of family E. Genotyped individuals are indicated with 
 
(*). B) Fundus photographs of left & right eyes of patient IV:3 showing waxy 
pale disc appearance and myopia. 
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Figure 3.6 (A) Pedigree of family F. Genotyped individuals are marked by (*). 
B) Fundus photographs of left & right eyes of patient IV:3 showing waxy pale 
disc appearance, pigmentary changes and thinning of the blood vessels. 
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Figure 3.7 (A) Pedigree of family G. Individuals IV-3 and IV-4 are 
monozygotic twins. Genotyped individuals are shown with (*). B) Fundus 
photographs of the right eye of patient IV:3 also depicts pigmentary changes in 
the retina. 
 
 
 
 
 
 
 
 
 
 
Linkage Analysis of Pakistani Families with Autosomal Recessive Retinitis Pigmentosa 78 
Chapter 3 Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Pedigree of family H. White and Black symbols represent normal and 
affected individuals respectively. Double lines represent consanguineous marriages. 
Genotyped individuals are shown with (*). Fundus photographs not available. 
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I:1       I:2        
 
          
 
          
 
          
 
          
 
 
II:1 II:2 
 
 
 
III:1 III:2 
 
II:3 II:4 
 
 
III:3 III:4 
 
        
  IV:1*   IV:2* 
D16S3100 (53.41) 2 1  1 2 
D16S3145 (54.05) 1 1  1 2 
D16S3120 (55.34) 21   1 1 
D16S690 (56.84) 1 1  2 1 
D16S409 (59.32) 1 2   2 1 
D16S540 (59.71) 2 1   2 1 
D16S261 (60.27) 2 1   2 1 
D16S517 (60.58) 2 1   2 1 
D16S3136 (62.43) 2 1  1 2 
D16S770 (64.61) 2 1  1 2 
D16S415 (67.62) 1 1   2 1 
D16S3034 (67.62) 2 1  1 3 
D16S489 (72.82) 1 1   1 2 
D16S3057 (76.09) 1 1   2 1 
D16S3132 (80.39) 1 2   2 1 
        
        
        
 
  V:1* V:2* V:3* V:4* 
D16S3100 (53.41) 2 1 1 2 1 2 1 2 
D16S3145 (54.05) 1 1 1 2 1 2 1 2 
D16S3120 (55.34) 1 1 1 1 1 1 1 1 
D16S690 (56.84) 1 2 1 1 1 1 1 1 
D16S409 (59.32) 1 2 1 1 1 1 1 1 
D16S540 (59.71) 1 2 1 1 1 1 1 1 
D16S261 (60.27) 1 2 1 1 1 1 1 1 
D16S517 (60.58) 1 2 1 1 1 1 1 1 
D16S3136 (62.43) 1 2 1 1 1 1 1 1 
D16S770 (64.61) 2 1 1 2 1 2 1 2 
D16S415 (67.62) 2 1 1 2 1 2 1 2 
D16S3034 (67.62) 1 2 1 1 1 1 1 1 
D16S489 (72.82) 2 1 1 3 1 2 1 2 
D16S3057 (76.09) 1 1 1 1 1 1 1 1 
D16S3132 (80.39) 1 1 2 1 1 1 1 1 
 
Figure 3.9 Haplotype of family B showing HBD region flanked by D16S3120 and 
D16S770 markers on chromosome 16p12.1-q12.1. Genotyped individuals are 
indicated with (*). The genetic positions are in accordance to Rutgers physical map 
build 37. 
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Table 3.1 Two point and multipoint LOD score values for locus at 16p12.1- q12.1 in 
 
Family B 
 
 
Markers Genetic Distance Multipoint LOD Two Point LOD Score at 
 (cM) Score Recombination Fraction 
   Zero 
    
D16S3100 53.41 -1.5410 -Infinity 
D16S3145 54.05 -0.7628 -Infinity 
D16S3120 55.34 -0.4711 -Infinity 
D16S690 56.84 2.2682 0.8234 
D16S409 59.32 2.2769 0.8234 
D16S540 59.71 2.2769 0.8234 
D16S261 60.27 2.2769 0.8234 
D16S517 60.58 2.2769 0.8234 
D16S3136 62.43 2.1970 0.8234 
D16S770 64.61 -Infinity -Infinity 
D16S415 67.62 1.6905 -Infinity 
D16S3034 67.62 -1.5400 -Infinity 
D16S771 70.35 -0.6916 -Infinity 
D16S489 72.82 -Infinity -Infinity 
D16S3140 73.96 -Infinity -Infinity 
D16S3057 76.09 1.4150 -Infinity 
D16S3132 80.39 -Infinity -Infinity 
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Table 3.2 Members of every family analyzed by SNP array 
 
 
 
Family ID 250K NSP Analysis 
A IV:2, IV:3, V:1, V:3 , V:5 
C V:3, V:7, V:8 
D VI:2, VI:3, VI:4 
E IV:3, IV:4, V:5, V:6, V:7 
F IV:3, IV:4, IV:5 
G IV:3, IV:4 
H V:4, V:5, V:6 
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Table 3.3 SNP data analysis of families A-G analyzed by Homozygositymapper 
 
Family Chromosome Start SNP End SNP Length Genes 
 
     C2ORF71- 
 
     FAM161A- 
 
A 2 rs6707606 rs7562696 10 Mb ZNF513 
 
 2 rs1429410 rs1356314 2 Mb VSNL1 
 
C 8 rs4445224 rs7006704 17.7 Mb C8ORF37- RP1  
  
 
 8 rs12056435 rs7842637 14.4 Mb --- 
 
 
8 
rs6420176 rs10096760 
1.3 Mb ---     
 
 8 rs4554493 rs2576586 8.0 Mb ---  
   
 
 
8 
rs1030528 rs2062457 
7.5 Mb ---     
 
 8 rs16922635 rs4738897 3.6 Mb ---     
 
 8 rs1913277 rs10957017 1.2 Mb ---  
   
 
D 2 rs243021 rs4671202 7.6 Mb FAM161A 
 
E 5 rs10077199 rs185435 19 Mb ---    
 
 22 rs9607084 rs7287643 11.6 Mb --- 
 
 11 rs10838573 rs17638028 10 Mb --- 
 
 9 rs10816370 rs2767000 9 Mb DFNB31 (USH2D) 
 
 15 rs3098585 rs4354896 3.7 Mb TRPM1 
 
F 6 rs818290 rs12191369 5 Mb LCA5 
 
 8 rs3200218 rs7009693 2 Mb --- 
 
 12 rs1167096 rs10877354 16.7 Mb RDH5 
 
G 1 rs1309332 rs4846064 4 Mb NMNAT1 
 
 8 rs2616482 rs39510 1.7 Mb ---  
   
 
H 2 rs12713048 rs2626399 3.4 Mb --- 
 
 3 rs16861032 rs6804798 20Mb --- 
 
 3 rs1915304 rs923471 10Mb --- 
 
 3 rs1489816 rs796515 9.9Mb --- 
 
 3 rs4682545 rs864727 2.6Mb --- 
 
 9 rs13302201 rs1627536 1.2 Mb --- 
 
 11 rs10836443 rs11606200 12Mb --- 
 
 11 rs2666559 rs2450252 4.9 Mb --- 
 
 11 rs11228904 rs506846 4.7 Mb --- 
 
 11 rs543695 rs540141 3.2 Mb --- 
 
 18 rs9950873 rs899111 66 Kb --- 
 
 19 rs1036217 rs855614 5.2 Mb --- 
 
 19 rs10407049 rs6510303 1.8 Mb --- 
 
 19 rs8103067 rs6510303 1.3 Mb --- 
 
 8 __  _--- __  ---____ _  ---____ CNGB3 
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Figure 3.10 Homozygositymapper SNP data analysis of the A family showing two 
significant homozygous region (red bars) on chromosome 2. (Chr= Chromosome) 
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Figure 3.11 Genome-wide Homozygosity Mapping of Family C affected individuals 
 
revealed   large   homozygous   regions   on   chromosomes   4,5,7,8,10   & 15. 
(Chr= Chromosome)  
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Figure 3.12 Genome-wide homozygosity mapping of family D affected individuals 
revealed large homozygous regions on chromosomes 2. (Chr= Chromosome) 
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Figure 3.13 Homozygositymapper SNP data analysis of family E showing several 
significant homozygous region (red bars) on chromosomes 5, 9,11,15,22. (Chr= 
Chromosome) 
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Figure 3.14 Genome wide Homozygosity of the F family analyzed by 
Homozygositymapper revealing three significant regions (indicated by red bars) of 
Homozygosity by descent (HBD) on chromosomes 6, 8 and 12. (Chr= Chromosome) 
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Figure 3.15 Homozygosity mapping of family G identified two significant HBD 
region (red bars) on chromosomes 1 & 8. (Chr= Chromosome) 
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Figure 3.16 Homozygositymapper SNP data analysis of family H showing several 
significant homozygous region (red bars) on chromosomes 2, 3, 9, 11, 18 & 19. (Chr= 
Chromosome) 
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IV:1 Heterozygous Carrier A/C 
 
-2A>C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V:12 Homozygous Mutant C/C 
 
-2A>C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17 Electropherogram analysis of the novel acceptor splice site mutation, 
identified in C8ORF37 gene, among the affected and unaffected family members in 
family C. Black arrow identifies the site of splice site variation. 
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VI:2 Homozygous Wild Type T/T IV:5 Heterozygous Carrier +/delT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VI:4  Homozygous Mutant Type delT/delT 
 
 
 
 
Figure 3.18 Cosegregation of FAM161A mutation (c.786delT) in family D. Individual 
VI:2 and IV:5 are normal while VI:4 is affected. Black arrow identifies the site of 
variation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Linkage Analysis of Pakistani Families with Autosomal Recessive Retinitis Pigmentosa 89 
Chapter 3 Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.19 Schematic representation of FAM161A gene and localization of the 
currently identified mutations. Black bars indicate the exons and white bards 
represent the 5′ and 3′ un-translated region (UTR), respectively. Majority of the 
known mutations localize to exon 3 and found in Israel and Palestinian territories; 
the novel p.I241Thrfs mutation found in this study shown in red is identified from 
Pakistan. 
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IV:4  Homozygous Mutant A/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
III:2  Heterozygous Carrier G/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IV:6  Homozygous Wild Type G/G 
 
 
 
Figure 3.20 Co-segregation of c.25G>A in exon 2 of NMNAT1 gene in family G. 
Individuals IV:4 and III:2 are unaffected and IV:6 is affected. 
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V:3 Homozygous Wild Type A/A IV:3 Heterozygous A/G 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V:3Heterozygous A/T V:2 Homozygous Wild Type A/A 
 
 
 
 
 
Figure 3.21 A) Sequence chromatogram of Exon 28 c.5653 A>G variation in USH2A 
gene within family A. IV:3 and V:3 are affected members. B) Sequence 
chromatogram of Exon 67 c.14662 A>T of USH2A within family A. V:3 is affected 
while V:2 is normal. Black arrow identifies the site of variation in both exons. 
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IV:1 Homozygous Wild type G/G III:1 Heterozygous Carrier A/G 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IV:4 Homozygous Mutant A/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.22 Mutation analysis of TRPM1 gene in family E. Sequence of the affected, 
carrier and unaffected individuals show the segregation of c.1600G>A. Red arrow 
identifies the site of variation. 
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V:3 Homozygous Wild type G/G V:6 Heterozygous G/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V:7 Homozygous Wild type G/G 
 
 
 
 
Figure 3.23 Sequence chromatogram for CNGB3 variation in family H. V:3 is 
unaffected while V:6 and V:7 are affected. An affected individual V:7 is homozygous 
for c.1208G>A variant and thus indicates the spurious nature of this already reported 
variation. Black arrow identifies the site of variation. 
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I:1            I:2 
 
 
 
II:1 II:2 II:3 II:4 
 
 
 
III:5 III:6 
 
III:1 III:2  III:3 
     
      
 IV:1 IV:2 * IV:3* IV:4* IV:5 
D2S 2199 (31.44) 11 11 11  
D2S312 (33.65)  11 11 11  
D2S2295 (36.80) 11 11 12  
D2S272 (37.97) 11 11 12  
D2S2346 (37.97) 11 11 12  
D2S1360 (38.92) 11 11 12  
D2S320 (39.03) 11 11 12  
D2S175 (40.86) 11 11 11  
D2S2342 (42.06) 11 11 11  
D2S220 (43.62)  11 11 11  
D2S158 (48.51)  11 11 11  
D2S174 (48.64)  11 11 11  
        
        
        
 
  V:1* V:2* V:3* V:4* V:5* 
D2S2199 (31.44) 11 11 11 11 11 
D2S312 (33.65) 11 12 11 11 12 
D2S2295 (36.80) 11 12 11 12 11 
D2S272 (37.97) 11 12 11 12 11 
D2S2346 (37.97) 11 12 11 12 11 
D2S1360 (38.92) 11 12 11 12 11 
D2S320 (39.03) 11 12 11 12 11 
D2S175 (40.86) 12 12 11 12 12 
D2S2342 (42.06) 11 11 11 11 11 
D2S220 (43.62) 11 11 11 12 11 
D2S158 (48.51) 11            12     11 11 11 
D2S174 (48.64) 11 12 11 11 11 
 
 
Figure 3.24 Haplotype of family A showing a HBD region flanked by D2S312 and 
D2S220 markers on chromosome 2p24.3-p24.2. Genotyped individuals are indicated 
with (*). The genetic positions are in accordance to Rutgers physical map build 37. 
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Table 3.4 Multipoint and Two-point LOD score values obtained for family A 
 
 
Markers Genetic Distance Physical Distance Multipoint LOD Two Point LOD Score 
 (cM) (Mb) Score Recombination Fraction 
    Zero 
     
D2S 2199 31.44 12.9 - Infinity 0.1520 
D2S312 33.65 15.2 - Infinity 0.000 
D2S2295 36.80 16.4 1.9310 1.8062 
D2S2346 37.97 16.8 1.9311 1.8062 
D2S272 37.97 16.8 1.9311 1.8062 
D2S1360 38.92 17.3 1.9311 1.8062 
D2S320 39.03 18.2 1.9311 1.8062 
D2S175 40.86 19.8 -Infinity 0.000 
D2S2342 42.06 20.1 -8.8127 0.000 
D2S220 43.62 21.08 - Infinity 0.000 
D2S158 48.51 22.8 - Infinity 0.1520 
D2S174 48.61 22.8 -1.6736 0.000 
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Figure 3.25 Sequence analysis of the cDNA of V:13 (proband). Sequence analysis 
of mutant and wild type alleles identified a 22 bp deletion in mutant allele obtained 
from the patient of family C. The wild type allele was obtained from the in-vitro 
mutagenesis of the mutant allele cloned from the DNA sample of individual V:13. 
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Figure 3.26 A) Results from sequencing reads were blatted with the UCSC Genome 
Browser. The double line indicated as 'Your sequence' starting from intron 4-5 of 
LCA5 gene and stretching into the intergenic region indicates the region of the 
deletion in the genome. B) Schematic representation of LCA5 deletion. Red color 
indicates the 110540 bps stretch of deletion while green depicts the 1.2 Kb intact 
region within the 4-5 intronic region and the 32 kb intact portion downstream the 
SH3BGRL2 gene. Arrow indicates the breakpoint and the insertion of single 
nucleotide 'A' in the altered sequence. 
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Marker IV:4 (A) IV:2 (N) IV:5 (A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.27 Gel electrophoresis showing the segregation pattern of the LCA5 
deletion in the affected and unaffected individuals using primers flanking the 
breakpoints. Affected individuals are shown as 'A' and unaffected individuals 
are shown as 'N' (Heterozygous Carrier). 
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DISCUSSION 
 
Hereditary retinal dystrophies (RD) consists of a large group of diseases characterized 
by clinical variability and pronounced genetic heterogeneity and are caused by 
mutations in over 300 genes. RDs can be subdivided into different groups based on 
the nature of disease, mode of inheritance and nature of photoreceptor cells 
degeneration. Additionally, RDs are grouped on the basis of age of onset and may 
appear early in life like LCA and CSNB or display late onset progressive vision loss 
like RP. Although earlier studies have explored several RD families, but underlying 
genes and mutations are still unknown for significant proportion of Pakistani families. 
Like other types of RDs, retinitis pigmentosa is also a heterogeneous group of 
progressive retinal disorders causing the degeneration and loss of retinal 
photoreceptor cells (Jen-Zen Chuang et al., 2004). With a prevalence of 1 in every 
4,000 cases, it is the most common retinal degeneration initially presented with night 
blindness followed by the progressive loss of peripheral vision leading to the 
blindness (Liping Yang et al., 2014). Till date over 50 different genes have been 
identified to cause RP. 
 
Consanguineous marriages are common in developing countries. Studies from various 
south asian countries revealed a prevalence of 20-70% of cousin marriages. Pakistan 
is a country where consanguineous marriages are widely practiced as a social norm 
(Ansari et al., 2004). Family relationships and maintaining the family land and wealth 
are among the reasons which make this practice favorable to most of the communities 
in Pakistan (Hussain, 1999). Studies have revealed that 60% of the marriages in 
Pakistan are consanguineous and 80% are particularly first cousin marriages (Hussain 
and Bittles, 1998). Due to the high prevalence of consanguinity in Pakistan 96% of the 
retinal diseases (RD) are associated with autosomal recessive mode of inheritance. Of 
these disorders arRP was detected to be the most common (59%) type of RD among 
the Pakistani population (Khan et al., 2014). 
 
The present study describes genetic analysis of eight consanguineous families 
originated from three provinces of Pakistan. Six of these families were collected from 
the Punjab but one family each was recruited from Sindh and Khyber Pakhtunkhwa 
provinces. All eight families originated from rural populations with inadequate 
diagnostics facilities and were identified through local hospitals around their places of 
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residences. However these families were diagnosed as RP by the local clinicians but 
our genetic studies indicates the involvement of non RP genes in some of these 
families, which highlights the importance of genetic testing especially in regions with 
insufficient diagnostics facilities. This is not totally unexpected as similar cases have 
already been reported from different populations (Almoguera et al., 2015; Xu et al., 
 
2015). Additionally misdiagnosis can also result due to the extreme overlap between 
the clinical presentation of different types of RDs and occasionally it become difficult 
to distinguish RP from other types of retinal dystrophies. 
 
Family A is a large family originated from a remote village of Punjab province of 
Pakistan and presents clinical symptoms compatible to autosomal recessive RP. The 
clinical diagnosis is also supported by the fundus examination of affected individuals 
IV:2 and V:1 which clearly showed depigmentation of the peripheral retina, waxy 
disk pallor, severely attenuated vessels and bony spicules formation. DNA samples 
from five members (IV:2, IV:3, V:1, V:3 & V5) of this family underwent genome-
wide SNP analysis which identified two homozygous regions on chromosome 2. Four 
candidate genes i.e ZNF513, C2ORF37, FAM161A and VSNL1 were sequenced in one 
affected member of family A, due to the reports of prior association with either RP or 
RDs. ZNF513 encodes a protein which acts as a transcription factor involved in retinal 
development. In situ hybridization has shown that ZNF513 is highly expressed in the 
retina including the photoreceptor cells, outer and inner nuclear layer. Studies on 
zebrafish have revealed that the ZNF513 mRNA has high expression levels in the 
early developing embryo brain and eyes and the knockdown of ZNF513 protein 
causes defective retinal development and photoreceptor loss in the zebrafish embryos 
(Li et al., 2010). C2ORF71 encodes a protein of 1,288 amino acids long expressed 
specifically in the retina without any known functional domains. Patients with 
mutations in C2ORF71 express the typical features of Retinitis pigmentosa (Downs et 
al., 2013). Visin like 1 (VSNL1) also known as Visinin-like protein 1 (VILIP-1) is 
from the neuronal calcium sensor family of Ca2+-myristoyl switch proteins which 
arrange signal transduction in the brain and retina (Polymeropoulos et al., 1995). 
Defects in the FAM161A are known to disrupt photoreceptor ciliary function however 
FAMA161A was recently recognized to be a member of the protein network involved 
in Golgi maintenance, intracellular transport and centrosome organization suggesting 
broader and novel cellular functions that may affect molecular pathology of retinal 
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disorders (Di Gioia et al., 2015). However sequencing of all coding and non-coding 
exons and intronic boundaries of ZNF513, C2ORF37, VSNL1 and FAM161A did not 
identify any pathogenic mutation. For further confirmation one affected individual of 
the family undergoes RD panel based next generation sequencing which only 
identified two heterozygous c.5653 A>G and c.14662 A>T variants in USH2A gene. 
But further follow-up of both variants ruled out the segregation of the both variants 
with disease phenotype in family A. The c.5653 A>G variants is present in 
heterozygous state in 15 ExAC individuals but c.14662 A> is homozygous and 
heterozygous in 11 and 209 ExAC individuals. Though c.5653 A>G is reported as a 
known USH2A variant (Dreyer B et al., 2008), but it does not explain the autosomal 
recessive RP in the affected individuals of family A. In order to explore the further 
possibilities, additional members of this family were genotyped for microsatellite 
markers mapped within the homozygous region identified on chromosome 2. A 1.7 
Mb region on chromosome 2p24.3- p24.2 was identified as homozygous in all 
affected members and yielded a multipoint LOD score of 1.93. The absence of 
pathogenic variation in four candidate genes and RD panel sequencing data support 
the mapping of new gene in family, which could be identified through exome 
sequencing. 
 
Family B is a consanguineous family enrolled from Sind province of Pakistan. STS 
marker based homozygosity mapping and linkage analysis mapped th disease locus to 
chromosome 16p12.1-q12.1. It consists of a genetic stretch of 10.5 cM and 
corresponds to a 24.5 Mb genomic region. This region contains over 50 known genes 
but only two genes CLN3 and ZNF423 have been associated with retinal degeneration. 
However loss of vision linked to both the genes is not the only symptom of the 
diseases but include a broad spectrum of features. Batten disease (juvenile neuronal 
ceroid lipofuscinosis, JNCL) is a frequent disease of early childhood presenting with 
progressive vision loss, mental damage, motor deficits and premature death, with a 
high prevalence of 1 in 21 000 caused by mutations in the CLN3 gene. It is highly 
expressed in the cerebral cortex, hippocampus and the cerebellum of the brain and 
neuronal cells without involving other organs. Investigations on mouse model of 
juvenile neuronal ceroid lipofuscinosis (Batten disease) has revealed that the cause of 
retinal degeneration in this disease appear to be neuronal and the complete loss of 
outer retinal layer leads to loss of both cell bodies and synaptic layers (Goebel et al., 
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1999; Sappington et al., 2003). Mutations of the ZNF423 gene can cause both 
Nephronophthisis and Joubert syndrome affecting the function of different organs 
including retina. These mutations are known to affect the structure of the cilia and 
disrupt certain downstream signaling pathways such as Wnt (Germino, 2005) and 
Shh, (Huangfu & Anderson 2005). Neither of the Batten disease or Joubert syndrome 
symptoms were observed in the affected members of family B, which helped us to 
rule out these genes as causative factor in this family. This is further supported by 
Sanger sequencing of CLN3 gene without the identification of any pathogenic variant. 
Further follow up with exome sequencing can help to identify the underlying 
pathogenic variation responsible for RP in this family. 
 
Family C with multiple affected individuals originated from Dera Ghazi Khan in the 
Punjab province of Pakistan. Though genome-wide homozygosity mapping identified 
several autozygous regions on various chromosomes including a 14.4 Mb region on 
chromosome 8q21.3-q22.3, but Sanger sequencing of C8ORF37 gene in an affected 
individual uncovered a putative splice site mutation (c.244 -2A>C). The mutation is 
predicted to alter the splice acceptor site of exon 3 which was confirmed by using 
mini gene splice assay. The mini gene assay indicated the loss of splice acceptor site 
of exon 3 and the activation of a cryptic splice site within exon 3, which result in the 
deletion of 22 nucleotides. This 22 nucleotide deletion results in a frameshift and 
premature truncation of the protein. So the novel splice site mutation recognized in the 
members of family C, probably results in loss of function of C8ORF37 gene product 
which is the cause of RP in this family. C8ORF37 was initially reported by Alejandro 
Estrada-Cuzcano et al in (2012) in families with arRP and arCRD. It spans 23,203 
nucleotides of the DNA and consists of six exons that encode a 23381 kDa protein of 
207 amino acids. Sequence analysis of all six coding exons identified four different 
pathogenic variants in eight affected individuals (Alejandro Estrada-Cuzcano et al., 
2012). Two patients of the study were reported with postaxial polydactyly with an 
extra finger or toe on the hand or foot, considering that polydactyly is a characteristic 
of Bardet-Biedl syndrome (BBS) (Beales et al., 1999) the study suggests that 
C8ORF37 mutations might also contribute to extra ocular abnormalities (Alejandro 
Estrada-Cuzcano et al., 2012). Immunolocalization studies determined that C8ORF37 
is localized at the base of the connecting cilium, suggesting ciliary function 
(Alejandro Estrada-Cuzcano et al., 2012). C8ORF37 has high RNA expression levels 
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in adult human retina and immunolocalization studies of 30 day mouse retina showed 
strong expression at the base of the photoreceptor connecting cilia. These findings 
provide support to the ciliary role of C8ORF37 gene. Nevertheless due to the absence 
of known functional protein domains, it is hard to indicate role of this gene in the 
retina. Recently a novel homozygous splice-donor-site mutation, c.243+2T>C was 
identified in C8ORF37 to be the cause of arRP in Thai patients. This mutation is 
thought to introduce a premature termination codon (PTC) causing activation of the 
nonsense mediated mRNA decay (NMD) pathway (Jinda et al., 2014). 
 
Family D is a six generation family with expression of autosomal recessive RP. 
Homozygosity mapping in this family identified a single region on chromosome 2 and 
further follow up indicated the involvement of FAM161A gene, which was initially 
identified in an Indian family with autosomal recessive RP (Gu et al., 1999; 
Langmann, et al., 2010). Sanger sequencing of all coding and flanking introns and 
UTR sequences of this gene led to the identification of a homozygous null mutation 
(c.786delT, p.I262Mfsx38) in exon 3, which probably results in a frameshift followed 
by a premature stop codon. Segregation analysis within the family revealed that the 
deletion segregates with RP phenotype in this family. Other FAM161A mutations of 
exon 3 reported till date consist of nonsense mutations (p.Arg229X) (p.Arg437X) in 
Indian and German families (Langmann, et al., 2010; Zach et al., 2012), deletion 
mutation c.1355_6delCA (p.Thr452SerfsX3), nonsense mutation of c.1567C>T 
(p.Arg523X) and a null mutation in exon 5 c.1786C>T (p.Arg596X) in families from 
Israel and the Palestinian territories bearing various origins, including North African 
Jews, Ashkenazi Jews, Syrian Jews, and Arab Muslims (Bandah-Rozenfeld et al., 
2010), nonsense mutation of c.1003C>T/p.R335X in a family from the Palestinian 
Arabic population descriptions (Zobor et al., 2014) (Figure 3.19). 
Immunohistochemical and proteomic analysis have indicated that FAM161A localizes 
in the connecting cilium, basal body, and the adjacent centriole of the photoreceptors 
in humans and mice suggesting that it may be involved in transport processes across 
the photoreceptor cilium. Majority of the currently mutations cluster in exon 3 of the 
FAM161A gene which is the largest coding exon (Figure 3.19). It encodes a highly 
conserved UPF0564 domain which is crucial for both homo- and heterotypic protein– 
protein interactions with the ciliopathy proteins Cep290 and lebercilin (Zach et al., 
2012, Karlstetter et al., 2014). So based on these findings it is anticipated that the 
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deletion mutation identified in the affected members of the family D results in the 
absence of functional FAM161A protein in human retina, which causes RP in the 
affected individuals. This is the first report of a FAM161A mutation that leads to 
progressive RP in a family of Pakistani origin. 
 
Homozygosity mapping of family E identified multiple autozygous regions bearing over 
20 RD or RP related genes. RD panel next generation sequencing performed on proband 
IV:3 to ruled out the disease causing gene in this large four generation consanguineous 
family and leads to the classification of a known homozygous missense mutation 
c.1600G>A in exon 14 of the TRPM1 gene (Van Genderen et al., 2009). TRPM1 located 
on chromosome 15q13.3 encodes an 182178 Da protein. This calcium permeable cation 
channel protein is also expressed in melanocytes and may play a role in melanin 
synthesis. The function of the visual system relies in the ON bipolar cells which are 
connected to the photoreceptors through synapses. The ON bipolar cells express 
metabotropic glutamate receptor (mGluR6). At the synapse glutamate binds to the 
mGluR6 receptor allowing it to couple with Go class of G protein. Activation of mGluR6 
and Go, results in closure of TRPM1 which is the primary channel responsible for the 
synaptic responses. TRPM1 is identified as transient receptor potential cation channel 
subfamily M member 1 (TRPM1) and has a negative regulation to the mGluR6/Go 
cascade in such that activation of the cascade results in closure of the TRPM1 channel 
which is a calcium permeable cation channel Upon interaction with light, mGluR6 
activation reduces, allowing the TRPM1 channel to open, while in the dark binding of 
glutamate to mGluR6 inhibits TRPM1 current (Shen et al., 2012). Mutations in any of the 
pathways will lead to complete congenital stationary night blindness (Maria et al., 2009, 
Dhingra et al., 2012). Mutations in the TRPM1 gene in both mice and humans impair 
retinal functioning at the bipolar cell level leading to reduced electroretinogram 
(ERG) b-wave while the a-wave remains normal (Klooster et al., 2011). In humans it 
causes congenital stationary night blindness (CSNB) and patients lack rod function 
and suffer from night blindness from early childhood. Till date mutations in 17 genes 
have been associated with CSNB worldwide. Although mutations have been 
identified in GRK1 (Azam et al., 2009; Zhang et al., 2005), SLC24A1 (Riazuddin et 
al., 2010), GNAT1 (Naeem et al., 2012), SAG (Waheed et al., 2012) and RDH5 
(Ajmal et al., 2012) genes, but this is the first report of the TRPM1 causing arCSNB 
in the Pakistani population. 
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Family F with multiple affect members enrolled from a rural village near Multan in 
Punjab province of Pakistan were initially diagnosed as RP but clinical re-evaluations 
after genetic analysis indicated the involvement of LCA. Genome-wide linkage 
analysis showed significant 5 Mb autozygous interval on chromosomes 6q14.1- 14.2 
which harbors LCA5 gene. Additional testing with DNA walking kit revealed a large 
in-frame deletion of exons1-4. Deletion mapping determine a novel deletion of 
110540 bps (g.[152634_42094] delins A) encompassing 42 kb of the coding and non 
coding regions of the LCA5 gene and 68 kb of the 5' upstream sequences including the 
promoter. A single nucleotide insertion was observed at the breakpoint within the 4-5 
intronic interval. This Interstitial deletion is predicted to abolish or reduce the 
assembly of basal transcriptional apparatus therefore disrupts the transcriptional 
regulation and normal process of gene activation. LCA5 encodes Lebercilin a 80554 
KDa protein of 697 amino acids was first studied in a consanguineous family of Swiss 
descendants from the Old Order River Brethren (Dharmaraj et al., 2000; den 
Hollander et al., 2007) who migrated to America in the 1750's in pursuit of religious 
freedom (Breckvill, 1972). LCA5 was first reported in Pakistan in a large 
consanguineous family with thirteen members including five affected individuals 
(Mohamed et al., 2003). LCA5 accounts for about less than 2% of LCA cases. 
Lebercilin localizes to the connecting cilia of photoreceptor cells (Jacobson et al., 
2009). The connecting cilium supports bidirectional intra flagellar transport of 
phototransduction proteins and membrane vesicles between the photoreceptor inner 
and outer segments, required for the assembly of cilia as well as recycling the 
axonemal turnover products (den Hollander et al., 2008; Boldt et al., 2011). This 
conserved transport system along the cilia and flagella is highly essential for the 
assembly and maintenance of these organelles (Blacque et al., 2008). Due to the 
activity of the phototransduction cascade, the photoreceptor outer segment undergoes 
immense turnover and phagocytosis by the RPE cells (Young, 1967). Boldt et al 
(2011) reported that lebercilin and lebercilin-associated proteins are not components 
of the IFT but are necessary for specialized transport machinery of the IFT. Mutations 
of LCA genes account for almost 70% of the cases where as the identification of 10 
mutations in contribution of LCA5 gene accounts for less than 3% (Ahmad et al., 
2011). Several LCA5 mutations have been reported in the Pakistani population. 
Ahmad et al (2011) reported a novel truncating mutation in exon 4 of 
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LCA5 (c.642delC). Den Hollander et al (2011) distinguished a homozygous 
frameshift mutation (1151delC; P384QfsX17) in exon 6 of LCA5. This family caries 
the largest deletion identified in the LCA5 gene till to date. 
 
The pedigree of family G also describes a consanguineous family of four generations 
with four affected members enrolled from Khyber PakhtunKhwa. SNP genotyping 
determined a 4Mb region on chromosome 1p36.23- p36.22 flanked by rs1309332-
rs4846064 harboring the gene NMNAT1. Sanger sequencing revealed a known 
homozygous missense mutation c.25G>A in exon 2 (Falk et al., 2012), resulting in a 
substitution of Valine by Methionine leading to the loss NMNAT1 enzymatic activity 
as a results of altered cellular NAD+ levels. NMNAT1 maps to chromosome 1p36 
within the LCA9 locus which was first described in 2003 by Keen et al in a large 
consanguineous Pakistani family. Koenekoop et al (2012) identified ten mutant alleles 
of NMNAT1 in eight families with LCA, consisting of one nonsense mutation 
(encoding p.Trp169), one read-through mutation (encoding p.280Gln) and eight 
missense mutations in unrelated individuals. In 2012 Falk et al reported the 
homozygous missense mutation (c.25G>A, p.Val9Met) in NMNAT1 suggesting that 
missense variation p.Val9Met may decrease NMNAT1 enzyme activity. Isabelle 
Perrault et al (2012) also provided further insights into the molecular bases of LCA by 
reporting a large number of NMNAT1 variants most of which are deleterious such as 
(c.518A>G, p.Asp173Gly), (c.542A>G, p.Tyr181Cys), (c.752A>C, p.His251Pro) and 
so on, in 22 different individuals. NMNAT1 (LCA9) is a 42 kb gene that encodes an 
enzyme required to generate NAD+ necessary in DNA metabolism and cell signaling 
(Lau et al., 2009). Our study support the work by Falk et al (2012), and provides 
further evidence of genetic and phenotypic heterogeneity of hereditary LCA in the 
Pakistani population and also highlight the issues of misdiagnosis. 
 
In family H multiple HBD regions were identified on chromosomes 2, 3, 9, 11, 18 & 
19. To sort out the underlying pathogenic variant, RD panel NGS was conducted on 
the DNA sample of individual V:5. Analysis identified a known missense mutation 
c.1208G>A (Khan et al., 2007) of exon 11 of the CNGB3 gene leading to altered 
protein function but this variant did not segregate in the other available members of 
this family. CNGB3 is member of the CNG genes (cyclic nucleotide-regulated 
channels) consisting of 18 exons that covers over 200kb of the genome (Kohl et al., 
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2000) present in the cone photoreceptor cells. These channels are activated by cGMP 
in the visual transduction cascade and have an essential role in the control of ionic 
flow across the photoreceptor outer segment membrane in the retina (Khan et al., 
2007). CNG channels consist of two α- and β-subunits essential for functional cation 
channel and generation of photo-responses in the cone cells. Mutation in either of the 
subunits will lead to Achromatopsia (Kohl et al., 1998, Kohl et al., 2000). Thus far 
mutations in five genes CNGA3, CNGB3, GNAT2, PDE6C and PDE6H have been 
associated to ACHM while CNGA3 and CNGB3 are major players of ACHM 
worldwide (Kohl et al. 2012). In 2003 Johnson and his group reported two novel 
mutations including c.595delG and c. 1573/4AA which resulted in truncated protein 
product. Thiadens and colleagues in 2010 reported two compound heterozygous 
mutations (p.R296YfsX9/p.R274VfsX12 and p.R296YfsX9/c.991-3T>g) in the 
CNGB3 gene. Wiszniewski et al in 2007 also reported a homozygous p.T383fsX 
mutation in patients with features associated to uniparental disomy (UPD) of 
chromosome 14. Based on the earlier reports on the critical function of the CNGB3 
gene in phototransduction cascade, this gene does not associate with the phenotype in 
the present family, therefore negates the diagnosis of achromatopsia in the affected 
members of family H. This is also supported by the available clinical profile of the 
affected individuals of this family, thus may provide the opportunity to identify a new 
gene responsible for RP in this family. 
 
Next generation sequencing is an efficient technique in parallel sequencing of 
multiple genes, generating millions of reads. This is a palpable advantage over the 
conventional Sanger sequencing where only a few hundred base pairs can be 
analyzed. NGS is among the most promising approaches in identification of causative 
mutations in genetically heterogeneous diseases like retinal dystrophies. However it 
was observed in our study that out of three families which were assessed by targeted 
NGS only one family was resolved while using the homozygosity mapping, genetic 
defects in all of five families were identified. Therefore this study supports the fact 
that homozygosity mapping is still a viable option to identify diseases causing gene, 
especially in resource limited setups. The identification of underlying genes in three 
unsolved families provides further support for either the genetic heterogeneity or the 
involvement of variants located in the non-coding regions. Our study highlights the 
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limitations of currently used techniques and also signifies that one approach cannot 
solve all the cases. 
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CONCLUSION 
 
 
 
Hereditary retinal dystrophies (RD) consists of a large group of diseases characterized 
by clinical variability and pronounced genetic heterogeneity and are caused by 
mutations in over 200 genes. RDs can be subdivided into different groups based on 
the nature of disease, mode of inheritance and primary degeneration of rod or cone 
photoreceptor cells. Although earlier studies have explored a number of RD families, 
but underlying genes are still unknown for significant proportion of Pakistani families. 
This study was conducted to identify the underlying genes in consanguineous 
Kindreds suffering from RP or RD and these families originated from rural 
populations of Pakistan ignored in the earlier studies. 
 
Our study indicates the heterogeneous nature of the RP in Pakistani population and 
results in the identification of three novel pathogenic variants and two known variants. 
Further evidence for genetic heterogeneity is provided by the three families negative 
for mutations and will be a useful resource for subsequent follow-up with genome or 
exome sequencing. Though the variants in NMNAT1 gene are already reported in 
Pakistani RD families, but this will be the first report of variant in TRPM1 gene. We 
could not identify the underlying genes in three families, which can be further 
followed up with exome or genome sequencing. On the basis of the gathered data, it 
can be concluded that C8ORF37, FAM161A, LCA5, NMNAT1 and TRPM1 variations 
are the major contributors for autosomal recessive retinal dystrophies in Pakistan. 
 
Theoretically the traditional screening methods (homozygosity mapping based 
candidate gene sequencing) were successful to solve majority of the families, but SNP 
based genome wide scan can be further improved to identify large deletion like LCA5 
identified in family F. At the same time, targeted next generation sequencing could 
only solve one out of three families, thus indicates the limitation of these arrays. 
However families or patients negative for variations via targeted next generation 
sequencing should be further followed up by exome or genome sequencing to cover 
most of the coding regions or to cover other important non-coding regions, 
respectively. This leads to the conclusion that an amalgamation of traditional and 
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modern molecular techniques is required for an accurate identification of mutations so 
that they can be followed by for further functional analysis. It is anticipated that these 
findings will contribute to future genetic testing in Pakistani families to minimize the 
risk of recessive disorders and to stratify and prioritize patients for an increasing 
number of clinical trials for gene and other forms of therapeutic intervention. 
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Retinal dystrophies are a heterogeneous group of inher-
ited eye disorders that lead to severe visual impairment and 
can cause blindness in a proportion of cases. Some forms are 
characterized by blindness at birth, while in others, symp-
toms appear during childhood or adulthood. The underlying 
pathology leading to loss of color, night, central, or peripheral 
vision can be accounted for by mutations in specific genes 
(see RetNet) known to disrupt crucial processes such as 
phototransduction, phagocytosis, vitamin A metabolism, 
cell-to-cell signaling, or gene regulation. These conditions 
can have dominant, recessive, X-linked, or mitochondrial 
modes of inheritance, and there is increased prevalence of 
retinal disease in communities with high levels of consan-
guinity [1-3]. Identifying the pathogenic mutation in the 
affected cases facilitates genetic counseling for prognosis 
and recurrence risk, as well as presymptomatic and carrier 
testing. It also serves to stratify and prioritize patients for an 
increasing number of clinical trials for gene and other forms 
of therapeutic intervention [4,5].
The aim of this study was to investigate the genetic basis 
of retinitis pigmentosa in two families of Pakistani origin, 
one from a rural village near Multan in the Punjab province in 
Pakistan and the other living in West Yorkshire in the United 
Kingdom (UK). Here we report previously undescribed muta-
tions in the recently implicated gene C8orf37 (OMIM 614477) 
as the cause of retinitis pigmentosa in these patients.
METHODS
Patient recruitment: Patients and their relatives were 
recruited after they gave informed, written consent using a 
process approved either by the Institutional Review Board 
of Quaid-i-Azam University (Project number IRB00003532) 
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or by the Leeds East Research Ethics committee (Project 
number 03/362) that adhered to the tenets of the Declaration 
of Helsinki and the ARVO statement on human subjects. In 
total, 5 affected (4 males and 1 female) and 8 unaffected (3 
males and 5 females) subjects were recruited either through 
a field visit to a remote village near Multan, Pakistan or 
through the eye clinic at St. James’s University Hospital, 
Leeds, England, followed by a home visit. Pedigree structures 
are depicted in Figure 1. The patients, aged between 12 to 27 
years old at the time of initial examination, were diagnosed 
with retinitis pigmentosa after ophthalmic assessment by an 
experienced ophthalmologist. Apart from problems with their 
vision they had no other obvious abnormalities. Peripheral 
blood (2–6 ml) was collected from affected patients, their 
parents, and unaffected relatives where they were avail-
able by venipuncture and drawn in BD Vacutainer EDTA 
blood collection tubes (BD Biosciences, Oxford, England). 
Genomic DNA was extracted from peripheral blood leuko-
cytes according to standard procedures.
Autozygosity mapping: Whole-genome homozygosity 
mapping was performed using Affymetrix Gene Chip Human 
Mapping 250 K-NspI arrays. The data were analyzed using 
Homozygosity Mapper software applying default settings.
Whole exome sequencing: Whole exome capture was 
performed on 3 µg of genomic DNA using the SureSelect 
Target Enrichment reagent version 4 (Agilent Technologies 
Limited, Wokingham, England) followed by deep sequencing 
using paired end reads on an Illumina HiSeq 2500 (Illumina, 
Little Chesterford, England) according to the manufacturer’s 
protocols. The sequencing output files were prepared and 
checked with FASTQ tools using the online data analysis 
platform Galaxy [6]. The sequencing reads were aligned to 
the human genome reference hg19 using Bowtie2 software [7] 
and processed in the SAM/BAM format [8] using Picard and 
the Genome Analysis Toolkit [9]. Single-nucleotide variants 
and indels were called using the UnifiedGenotyper [10]. Only 
variants with a prediction score of >20 were included in the 
analysis. Annovar software was used to annotate the variants. 
Any variants with a minimum read depth of 10, outside the 
exon and its flanking splice site regions, synonymous, with 
a minor allele frequency >1% in the exome variant server or 
the 1000 Genomes database were filtered out. The resulting 
list of homozygous gene variants was compared to the retinal 
dystrophy genes found in RetNet [June 2014].
Sanger sequencing: Primers for amplifying all exons and 
exon–intron boundaries of C8orf37 were designed with 
Primer3plus software and are listed in Appendix 1. PCR was 
performed on human genomic DNA with 10 pmol of forward 
and reverse primers, and 0.5 U of Taq DNA polymerase 
according to standard protocols. An initial denaturation step 
of 94 °C for 4 min was followed by 35 cycles consisting of 
94 °C for 15 s, 55-62 °C for 15 s and 72 °C for 30 s with a 
final extension step of 72 °C for 5 min. The products were 
treated with ExoSAP-IT (GE Healthcare, Freiburg, Germany) 
and sequenced using the BigDye terminator v.1.1 cycle 
sequencing kit (Applied Biosystems, Darmstadt, Germany) 
on an ABI 3130 Genetic Analyzer (Applied Biosystems). 
Results were analyzed using Lasergene SeqMan Pro soft-
ware (DNASTAR, Madison, WA). Purified plasmid DNA 
was sequenced directly using the BigDye Terminator v.1.1 
kit according to the manufacturer’s instructions.
Minigene splicing assay: To construct a minigene plasmid 
containing human C8orf37 exons 2 to 4 and the intersecting 
introns, a ~5 kb DNA fragment was amplified from genomic 
DNA using a Long PCR Enzyme kit (Fischer Scientific, 
Schwerte, Germany), with oligonucleotide primers dATA 
TAA GCG GCC GCG CTT TGC CTG CAG AAG GTA G 
and dATA TAA GGA TCC AAA TGC CAA TGG AAT 
Figure 1. Pedigrees of the two 
investigated families with retinitis 
pigmentosa. A: Family MA48. B: 
Family MA13. The arrow indicates 
the proband. Genotypes of the cases 
from whom DNA was available for 
analysis is indicated. M1=c.244–
2A>C and M2=c.555G>A. M1/
M1= homozygous mutant genotype; 
M1/+=heterozygous genotype.
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GTG CT that contained restriction enzyme recognition sites 
(underlined). This PCR fragment was digested with BamHI 
and NotI and then ligated into a double-digested pSPL3 
plasmid vector (Life Technologies, Darmstadt, Germany) 
using T4 DNA Ligase (New England Biolabs, Frankfurt am 
Main, Germany) according to the manufacturer’s instruc-
tions. Plasmid DNA of the wild-type minigene construct 
was purified from the transformed Escherichia coli host 
in the presence of ampicillin (Life Technologies), using the 
peqGOLD Plasmid Miniprep KitI (PEQLab Biotechnologie, 
Erlangen, Germany), and the integrity sequence was verified 
with restriction digests and sequencing as described.
To introduce a single nucleotide substitution into the 
minigene construct, site-directed mutagenesis was performed 
with oligonucleotide primers (dGGC CTT TTA TTG TTT 
TGC TTT TTT AAC AGA AAT TAA AAT CTA AAT CTT 
CAG GTA ACA C and dGTG TTA CCT GAA GAT TTA 
GAT TTT AAT TTC TGT TAA AAA AGC AAA ACA ATA 
AAA GGC C; the nucleotide mutation is underlined) using 
the QuikChange In Vitro Mutagenesis kit (Agilent Tech-
nologies, Santa Clara, CA) according to the manufacturer’s 
protocol. The mutated construct was partially sequenced to 
confirm that the desired change was introduced.
Minigene constructs containing either wild-type or 
mutant sequence were transformed into confluent HEK293 
cells using Lipofectamine 2000 (Life Technologies). After 24 
h, the cells were harvested. Then the total RNA was extracted 
(PEQLAB Biotechnologie), and reverse transcribed (Roche 
Diagnostics GmbH, Mannheim, Germany) before PCR 
amplification with vector-specific primers dTCT GAG TCA 
CCT GGA CAA CCT CAA and dGCT CAC AAA TAC CAC 
TGA GAT was performed. The products were analyzed with 
agarose gel electrophoresis and direct sequencing.
RESULTS
Clinical phenotype of patients: Two families, one from a rural 
village near Multan in Pakistan (MA48) and the other living 
in West Yorkshire in England (MA13), both of Pakistani 
origin, were investigated in this study. All affected cases had 
early onset retinitis pigmentosa with moderate to severe loss 
of visual acuity between the second and third decades. The 
fundus examination findings were consistent with a clinical 
diagnosis of retinitis pigmentosa (Table 1 and Figure 2). Two 
of three cases (48–3 and 863) that were examined had axial 
myopia with refractive errors between −5.5 and −9.5 diop-
ters. Full-field electroretinography was unrecordable in one 
patient (863), and another had sluggish pupillary reactions 
(48–2) consistent with a severe form of retinitis pigmentosa 
and minimally functioning retina. No other extraocular 
manifestations were observed in the patients who were 
examined. The family history and evidence of consanguinity 
suggested autosomal recessive inheritance (Figure 1).
Genetic analysis of families: To identify the causative 
mutation in family MA48, genomic DNA from the three 
affected cases, 48–2, 48–3, and 48–7, was analyzed with 
homozygosity mapping. Several homozygous regions on 
chromosomes 4, 5, 7, 8, 10, and 15 were shared by all affected 
individuals (Appendix 2). Of these, an approximate14.4 Mb 
interval on chromosome 8 contained the candidate gene 
C8orf37, which was recently implicated in retinal dystrophy 
with early macular involvement [11]. Sanger sequencing of 
all coding regions and flanking intron segments revealed a 
homozygous nucleotide substitution, c.244–2A>C in C8orf37 
[NM_177965.3], that disrupted the consensus acceptor splice 
junction of exon 3 (Figure 3A). This mutation segregated 
with the disease phenotype as expected in a recessive 
manner and was not present in 8,244 unrelated individuals 
of South Asian origin who had been whole-exome sequenced 
as part of various disease-specific and population genetic 
studies (accessed via. the Exome Aggregation Consortium 
[ExAC] browser, version 0.2). To analyze the precise effect 
of this mutation on transcript splicing, a minigene construct 
was generated containing exons 2 to 4 and the intervening 
intronic sequences of C8orf37. Following site-directed muta-
genesis to introduce the mutation, the wild-type and mutant 
constructs were transfected into HEK293 cells, total RNA 
was extracted, and reverse-transcription PCR was performed 
before Sanger sequencing. This showed that the splice-site 
mutation activates a cryptic splice site within exon 3, causing 
a 22 bp deletion in the transcript that predicts a frameshift 
and premature termination of protein translation (Figures 
3C,D).
In family MA13, genomic DNA from the proband 863 
was analyzed with whole exome sequencing. The output files 
were processed to generate 47,391 variants with a minimum 
read depth of 10. These variants were filtered to include those 
within exons as well as the conserved two base pair flanking 
splice-site junctions and that have a minor allele frequency of 
less than 1% in the public DNA databases. After synonymous 
variants were excluded, 73 homozygous variants remained 
in the filtered list (see Appendix 3). Of these, only reces-
sive mutations in C8orf37 had previously been implicated 
in retinal dystrophy [11]. It therefore seemed likely that the 
homozygous null variant in C8orf37, c.555G>A, p.W185*, was 
the most suitable candidate for causing the condition (Figure 
3B), and was later confirmed to segregate with disease in this 
family and was absent from 8,244 unrelated subjects of South 
Asian origin who had been accessed using the ExAC browser.
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DISCUSSION
C8orf37 encodes a 207 amino acid protein of unknown func-
tion with a predicted molecular mass of approximately 23 
kDa. Immunolocalization studies in retinal cross sections 
have shown that C8orf37 colocalizes with γ-tubulin, a basal 
body marker at the connecting cilium, between the outer and 
inner segments in the photoreceptor layer [11]. The basal body 
acts as the organizing center for the cilium and permits traf-
ficking of proteins and lipids through intraflagellar transport 
from the inner to the outer segment, that is necessary for the 
formation of the outer segment discs [12,13].
Here we describe novel mutations in C8orf37 that 
caused retinitis pigmentosa in two consanguineous families 
of Pakistani ethnicity. Mutations in C8orf37 are a rare cause 
of retinal dystrophy. To date, they account for only 0.4% of 
all unrelated retinal dystrophy cases (three out of 700) that 
have been solved in our laboratories. Previous papers on the 
clinical features seen in patients with mutations in this gene 
described six patients with a diagnosis of cone-rod dystrophy 
(CRD) and seven with retinitis pigmentosa (RP) with early 
macular involvement [11,14-17]. Distinguishing between 
RP, where patients experience night blindness followed by 
progressive visual field constriction, and CRD, where the 
symptoms are photophobia, loss of visual acuity, and central 
vision, depends on recognizing the early symptoms. However, 
in the most severe cases there is considerable phenotypic 
overlap at presentation making it difficult to diagnose these 
progressive conditions. Sometimes when features of both 
Figure 2. Fundus photographs of 
patient MA48–2 at 33 years old. 
Color (A) and black-and-white 
(B) photos of the right eye show 
diffuse nummular hyper-pigmen-
tation at the macula (arrows), waxy 
pallor of the optic disc, arteriolar 
attenuation, and chorioretinal atrophy. C: Fluorescein angiography of the left eye shows bone spicule-like deposits as fluorescent areas 
nasal to the optic disc (arrows). 
Figure 3. Genetic analysis of 
C8orf37. Sanger sequencing chro-
matograms depicting mutations 
c.244–2A>C in an affected indi-
vidual (48–3) from family MA48 
(A) and c.555G>A; p.W185* in 
an affected individual (863) from 
family MA13 (B). Chromatograms 
from a normal control subject 
are also shown for comparison. 
Diagrammatic representation of 
the minigene splicing assay (C) 
and sequencing chromatograms (D) 
showing that the consequence of the 
c.244–2A>C splice site mutation 
was activation of a cryptic splice 
site within exon 3 and deletion of 22 
base pairs of coding sequence in the 
resulting transcript. The wild-type 
minigene assay spliced exons 2 and 
3 correctly.
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conditions are present at the early stages it may be difficult 
to assign a disease category. Of the 73 genes that have muta-
tions that lead to RP and the 30 genes that have defects that 
lead to CRD (RetNet, October 2014), only mutations in seven 
genes, including C8orf37, account for patients with either 
diagnosis. These include dominant mutations in SEMA4A 
(OMIM 607292) [18] and PRPH2 (OMIM 179605) [19,20], 
recessive mutations in ABCA4 (OMIM 601691) [21-23] and 
CERKL (OMIM 608381) [24,25], X-linked mutations in 
RPGR (OMIM 312610) [26,27], and mutations in PROM1 
(OMIM 604365) that show a genotype-phenotype correla-
tion; a dominant missense mutation, p.Arg373Cys (dbSNP: 
rs137853006), causes CRD [28] whereas recessive mutations 
lead to RP [29,30].
A summary of all C8orf37 mutations found in patients 
with retinal dystrophy to date, together with the available 
clinical information in each case, is shown in Figure 4. Two 
of the patients with CRD, both harboring a homozygous 
splice-site acceptor change, showed unilateral postaxial 
polydactyly as an additional feature, which suggests the 
condition may be a ciliopathy [11]. The patients described in 
this report, including the one described by Jinda et al. who 
had a different homozygous splice-site mutation [15], did not 
present with extraocular features and polydactyly was absent. 
The clinical features of night blindness, visual field constric-
tion, and progressive loss of vision appeared to be consistent 
in all patients with C8orf37 mutations, whether the patients 
had a missense mutation or a null allele, suggesting that there 
does not appear to be a correlation between genotype and 
phenotype.
This is the first time that mutations in this gene have 
been described in the Pakistani population. To date, of the 132 
known genes that cause non-syndromic retinal dystrophies, 
only 35 have been found to be mutated in cases of Pakistani 
origin, and about 90% of the mutations in these 35 genes have 
not been found in other populations [31]. Finding the mutation 
in these families should facilitate counseling for recurrence 
risk and carrier testing. However, although approximately 
60% of marriages in Pakistan are consanguineous, one of the 
highest rates in the world [32], which is likely to contribute to 
the high burden of genetic disease [33], practicing physicians 
are required to perform counseling duties since specialized 
genetic counseling services are not part of the healthcare 
system in Pakistan [34] whereas the family living in England 
will have access to appropriate infrastructure such as ophthal-
mologists, clinical geneticists, and social services through the 
National Health Service.
To summarize, we have identified novel C8orf37 muta-
tions in two consanguineous families who originated in 
Pakistan. Our findings contribute further data on the pheno-
type and the spectrum of mutations in this form of retinitis 
pigmentosa.
APPENDIX 1. PRIMERS FOR SANGER 
SEQUENCING THE EXON AND INTRON 
BOUNDARIES OF C8ORF37.
The primer names, DNA sequences, PCR product size and 
melting temperatures of each primer are shown. To access 
the data, click or select the words “Appendix 1.”
APPENDIX 2. HOMOZYGOSITY MAPPING IN 
FAMILY MA48.
Analysis of the SNP genotyping data of affected cases 48-2, 
48-3 and 48-7 identified autozygous segments on chromo-
somes 4 (rs10212780 – rs3755967, ~7.1Mb), 5 (rs4357016 
– rs1443096, ~2.0Mb), 7 (rs6583338 – rs4724950, ~7.2Mb; 
rs4720204 – rs11771663, ~5.4Mb and rs6943120 – rs12706290, 
Figure 4. Diagram showing 
C8orf37 mutations that have been 
identified to date and diagnosis 
of the patient(s) in whom they 
were found. The n value denotes 
the number of patients with that 
mutation. Thus far, 18 patients 
with C8orf37 mutations have been 
described. The references that 
report the mutations are in super-
script with # representing mutations 
identified in the current study.
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~2.6Mb), 8 (rs4445224 – rs7842637, ~79.0Mb), 10 (rs6537586 
– rs1973972, ~61.5Mb) & 15 (rs16940472 – rs8042228, 
~2.4Mb) that are highlighted in red. The location of C8orf37 
which is at ~14.4Mb on chromosome 8 is depicted. To access 
the data, click or select the words “Appendix 2.”
APPENDIX 3. LIST OF VARIANTS IDENTIFIED 
AFTER FILTERING THE EXOME SEQUENCING 
DATA FROM PATIENT 863.
The chromosome, position, gene, coding effect, transcript 
accession number, exon, cDNA and protein changes as well 
as the minor allele frequencies in the exome variant server 
and the 1000 Genomes database are shown for the 73 homo-
zygous variants. The C8orf37 mutation is highlighted in bold. 
To access the data, click or select the words “Appendix 3.”
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